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The antimycotics suppress thymic stromal lymphopoietin production in human keratinocytes
CS Hau, N Kanda and S Watanabe Dermatology, Teikyo University School of Medicine, Tokyo,
Japan
Thymic stromal lymphopoietin (TSLP) is produced by epidermal keratinocytes, and it induces Th2-
mediated inflammation. TSLP expression is enhanced in lesions with atopic dermatitis, and is a ther-
apeutic target. Antimycotic agents improve the symptoms of atopic dermatitis. We examined whether
antimycotics suppress TSLP expression in human keratinocytes. Normal human keratinocytes were
incubated with polyinosinic-polycytidylic acid (poly I:C) plus IL-4 in the presence of antimycotics.
TSLP expression was analyzed by performing ELISA and real time PCR. Luciferase assays were per-
formed to analyze NF-κB activity. IκBα degradation was analyzed by performing western blot analy-
sis. Poly I:C plus IL-4 increased the secretion and mRNA levels of TSLP, which was suppressed by
an NF-κB inhibitor, and also enhanced NF-κB transcriptional activities and induced the degrada-
tion of IκBα in keratinocytes. The antimycotics itraconazole, ketoconazole, luliconazole, terbinafine,
butenafine, and amorolfine suppressed the secretion and mRNA expression of TSLP, NF-κB activ-
ity, and IκBα degradation induced by poly I:C plus IL-4. These suppressive effects were similarly
manifested by 15-deoxy-A-12,14-PGJ2 (15d-PGJ2), a PGD2 metabolite. Antimycotics increased the
release of 15d-PGJ2 from keratinocytes and decreased the release of thromboxane B2, a throm-
boxane A2 metabolite. Antimycotic-induced suppression of TSLP production and NF-κB activity
was counteracted by an inhibitor of lipocalin type-PGD synthase. In conclusion, antimycotics itra-
conazole, ketoconazole, luliconazole, terbinafine, butenafine, and amorolfine may suppress poly
I:C plus IL-4-induced production of TSLP by inhibiting NF-κB via increasing 15d-PGJ2 production
in the keratinocytes. These antimycotics may block the overexpression of TSLP in lesions with atopic
dermatitis.
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Reduced CD18 levels drive Treg conversion into Th17 cells in the CD18hypo PL/J mouse model
of psoriasis
K Singh,1 MV Gatzka,1 L Borkner,1,3 T Peters,1 H Hainzl,1 H Wang,1,2 AM Sindrilaru1 and
K Scharffetter-Kochanek1 1 Dermatology and Allergic Diseases, Ulm University, Ulm, Germany,
2 Shanghai Jiao Tong University School of Medicine, Shanghai, China and 3 HZI,
Braunschweig, Germany
Defective development and function of CD4+CD25high+Foxp3+ regulatory T cells (Tregs) con-
tribute to the pathogenesis of psoriasis and other autoimmune diseases. Little is known about the
influence of adhesions molecules on the differentiation of Foxp3+ Tregs into pro-inflammatory Th17
cells, occurring in lesional skin and blood of psoriasis patients. In the CD18hypo PL/J mouse model
of psoriasis reduced expression of CD18/β2 integrin to 2–16% of wildtype levels is associated with
progressive loss of Tregs, impaired cell-cell contact between Tregs and dendritic cells (DCs) as well
as Treg dysfunction as reported earlier. In the present investigation, Tregs derived from CD18hypo
PL/J mice were analyzed for their propensity to differentiate into Rorγt+ IL-17 producing Th17 cells
in vivo and in in vitro Treg-DC co-cultures. Adoptively transferred CD18hypo PL/J Tregs were more
inclined towards conversion into IL-17 producing Th17 cells in vivo in an inflammatory as well as
non-inflammatory environment compared to CD18wt PL/J Tregs. Addition of neutralizing antibody
against CD18 to Treg-DC co-cultures in vitro promoted conversion of CD18wt PL/J Tregs to Th17
cells in a dose-dependent manner similar to conversion rates of CD18hypo PL/J Tregs. Reduced
thymic output of nTregs and peripheral conversion of Tregs into Th17 cells therefore both con-
tribute to the loss of Tregs and the psoriasiform dermatitis observed in CD18hypo PL/J mice mice.
Our data overall indicate that CD18 expression levels impact Treg development as well as Treg
plasticity and that differentiation of Tregs into IL-17 producing Th17 cells is distinctly facilitated by
a subtotal deficiency of CD18.
005
Anti-inflammatory effect of a traditional Chinese medicine Qingpeng ointment on induced
atopic dermatitis in mice
Y Li, X Lu and L Li Dermatology, Peking University Third Hospital, Beijing, China
Background. Atopic dermatitis (AD) is a recurrent pruritic and chronic inflammatory disease. Qing-
peng ointment (QP) is a traditional Chinese medicine which has been used in the treatment of AD
in China, but the mechanism is unknown. Aim. To analyze the anti-inflammatory effects of QP on
induced AD in mice. Methods. AD lesions were induced in 108 eight-week-old BALB/c mice by
repeated application of 2, 4-dinitrofluorobenzene on shaved backs and the mice were then equally
divided into 6 groups to untreated group (model control), different concentration of QP (100%, 75%
and 50%) treated group, vehicle of QP treated group and Mometasone Furoate cream (MF) (posi-
tive control) treated group respectively, and treated for two weeks. Eighteen mice receiving no sen-
sitization or treatment served as blank normal control. Macroscopic and microscopic changes of
the skin lesions were observed after the treatment. The levels of serum immunoglobulin (Ig) E, tis-
sue interferon (IFN)-γ, interleukin (IL)-4 and IL-17A protein were measured with Enzyme-Linked
Immunosorbnent Assay (ELISA) and tissue mRNA expression of IL-4, IFN-γ and IL-17A was meas-
ured with quantitative real-time polymerase chain reaction (PCR). Results. Similar to MF, QP could
significantly inhibit the induced AD lesions in a dose-related pattern. Levels of serum IgE, tissue IL-
4 and the mRNA expression of IL-17A was suppressed by QP treatment while the tissue IFN-γ was
increased. Conclusions. QP could inhibit hapten induced AD lesions in mice by at least inhibition
of IL-4, IgE and IL-17A production and by increasing the tissue level of IFN-γ.
004
Programmed cell death1 (PD-1) regulates the effector function of autoimmune CD8 T cells
and protects against immune-related disease
N Okiyama and SI Katz Dermatology Branch, CCR, NCI, NIH, Bethesda, MD
PD-1 is an inhibitory molecule expressed by activated T cells. Its ligands (PD-L1 and -L2) are expressed
by many leukocytes and non-leukocytes. Recent clinical trials have shown that anti-PD-1 or anti-
PD-L1 blocking antibodies enhance cancer immunity. To assess the role of PD-1 in CD8 T cell-medi-
ated diseases, we used PD-1 knockout (KO)-OVA-specific T cell-receptor transgenic (Tg) CD8 T cells
(OT-I cells) in a murine model of graft-versus-host disease (GvHD). Mice expressing membrane-
bound ovalbumin in skin and mucosae (mOVA mice) develop a GvHD-like disease, manifested by
skin/mucosal lesions and weight loss, after transfer of 5×105 OT-I cells. Recovery begins 14 days
after adoptive cell transfer. We found that mOVA mice that received as few as 5×104 PD-1KO-OT-
I cells developed GvHD with intense skin and mucosal lesions and with significant weight loss (-
16.6%±2.7) by day 7, and mice required euthanasia by day 9. mOVA mice that received 5×104
wild-type OT-I cells did not develop lesions or weight loss (-1.1%±3.3, p<0.05; U test). FACS
analysis showed that PD-1KO-OT-I cells accumulated in skin-draining lymph nodes and spleens
(6.7% and 31.3%, respectively) of mOVA mice 7 days after cell transfer to a greater extent than wild-
type OT-I cells (1.8% and 2.9%). Four days after cell transfer, >90% of OT-I cells, CD4 T cells and
DCs expressed PD-L1, and 7 days after transfer 39.5% of CD4 T cells and 14.1% of DCs expressed
PD-L2. Consistent with our prior studies, when mOVA×OT-I double Tg (dTg) mice received 1×106
OT-I cells they did not develop GvHD, whereas dTg mice that received 1×106 PD-1KO-OT-I cells
developed disease with skin/mucosal lesions and weight loss (-15.3%±1.6, p<0.01; U test) at day
6. In aggregate, our data strongly suggest that the PD-1/PD-L1, -L2 system can influence the devel-
opment and/or progression of CD8 T cell-mediated immune disease. Enhancement of PD-1 or
PDL1/PDL2 expression by effector cells, accessory cells or target cells may attenuate CD8 T cell-
mediated diseases, including GvHD.
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The possibility of having the same pathogenesis of mycosis fungoides, large-and small plaque
parapsoriasis
A Sidikov, D Zaslavsky, R Nasyrov and Z Zouli Dermatology and Venerology, Saint-Petersburg
Pediatric Medical University, Saint-Petersburg, Russian Federation
Background: Large plaque parapsoriasis (LPP) and Small plaque parapsoriasis are general diseases,
which are related to cutaneous T-cell lymphoproliferative disorders, whose biological distinction
from early Mycosis Fungoides (MF) is still not clearly defined. Objectives: Some authors recently
have found the preponderance of immature dendritic cells (CD209/DC-SIGN) in MF and syndrome
Sezary lesions, while in the normal skin these cells were absent. The authors supposed that it is prob-
ably important for the mediation of immunological tolerance against malignant T-cells. Therefore,
the purpose of our study is to show the expression of CD209/DC-SIGN markers in order to investi-
gate the role of these markers in LPP and SPP. Methods: Three patients with LPP and seven patients
with SPP were included in the study. Skin biopsy were obtained from lesions well-circumscribed
round or oval pink patches. Patients with LPP lesions have patches with size more than 8-10 cm
and patients with SPP lesions have patches with size less than 5-6 cm in diameter. Immunohisto-
chemistry was performed on the paraffin tissue sections for CD209/DC-SIGN monoclonal anti-
bodies. Results: The study showed a significant infiltration of CD209/DC-SIGN in dermal infiltrate
in both conditions. Limitations: The number of patients was small. Conclusions: Our study possi-
bility demonstrates that LPP and SPP have the same pathogenetic mechanisms like MF and syn-
drome Sezary. The presence of immature dentritic cells (CD209/DC-SIGN) in dermal infiltrate
probably play important role in the mediation of immunological tolerance against malignant T –cells.
For the representative results of these pathogenetic mechanisms it needs a control group of patients
with non-chronic dermatitis.
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Human Langerhans’ cell migration can be inhibited by blocking β1 integrin function
FR Ali,1 RJ Dearman,2 S Ogden,1 KT Mellody,2 MJ Humphries,2 I Kimber2 and CE Griffiths1 1
Dermatology Centre, University of Manchester, Manchester, United Kingdom and 2 Faculty of
Life Sciences, University of Manchester, Manchester, United Kingdom
Langerhans’ cells (LCs) are the outermost sentinels of the immune system, with dual immunostim-
ulatory and immunoregulatory roles. Following stimulation with self or foreign antigen, LCs disen-
gage from neighbouring keratinocytes and migrate to draining lymph nodes. Integrins are bidirec-
tional signalling molecules associated with various aspects of cellular physiology, migration and
survival. They exist as heterodimers, with α and β subunits. LC migration in mice is contingent
upon functional α6 and α4 integrins with presumed β1 integrin partner subunits. We have investi-
gated the role of β1 integrin function in human LC mobilisation using an epidermal explant assay.
Four 6mm punch biopsies were taken from sun-protected skin of 6 healthy subjects (age 18-30y)
and incubated in ethylenediaminetetraacetic acid (EDTA) for 2h before the epidermis was mechan-
ically removed using forceps. For each subject, 1 epidermal sheet was fixed in acetone immedi-
ately (for baseline counts) and the remaining 3 sheets cultured at 37C for 24h in RPMI medium
alone or in the presence of 10ug/ml functional or non-functional rat anti-β1 integrin IgG2a mono-
clonal antibody. The sheets were stained with CD1a-fluorescein isothiocyanate (FITC) antibody
before LC counts were performed using immunofluorescent microscopy. Mean LC counts were 1131
+/- SD 253 per mm2 at baseline with approximately 18% LCs migrating at 24h in the presence of
either culture medium alone (mean LC count 933 +/- SD 270) or added non-functional anti-β1
integrin antibody (mean LC count 922 +/- SD 223). In the presence of functional anti-β1 integrin
antibody, LC migration was significantly reduced (p<0.01; mean LC count 1085 +/- SD 229; mean
migration 3.5%). These findings implicate functional β1 integrin-containing heterodimers in the
migration of LC from the epidermis. Future investigations will utilise the explant model to further
explore integrin subunit involvement in LC migration.
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Low numbers of memory T cells correlate with minor CCL27 expression in prenatal human
skin
M Mildner,1 M Prior,1 M Gschwandtner,1 C Schuster,1 E Tschachler1,2 and A Elbe-Bürger1 1
Dermatology, Medical University of Vienna, Vienna, Austria and 2 CE.R.I.E.S., Neuilly, France
CCL27, a chemokine constitutively expressed in the epidermis of adults, is a key chemo-attractant
for CLA+ memory T cells. Recently, it has been reported that, in contrast to adult skin, prenatal skin
harbors only few memory T cells. In this study we investigated whether this scarcity correlates with
CCL27 levels during gestation in vivo and analyzed its expression in fetal and adult human primary
keratinocyte (KC) as well as organotypic skin cultures in vitro. Immunofluorescence revealed no/low
CCL27 expression in embryonic (9-14 weeks estimated gestational age (EGA)) and fetal (18-24 weeks
EGA) human skin, respectively, as compared to the strong staining pattern observed in adult skin.
In line with this in situ expression pattern, secreted CCL27 was present in supernatants of ex-vivo
skin cultures derived from adult skin samples but was absent in supernatants of prenatal skin. Sim-
ilarly, CCL27 was produced and secreted in vitro by adult primary human KC but not in fetal pri-
mary human KC. Stimulation with the TLR3 ligand poly (I:C) - a potent inducer of a variety of
chemokines in KC - led to a strong induction of CCL27 secretion merely in adult but not in fetal
KC. Given that a major difference between pre- and post-natal epidermis is the differentiation sta-
tus of KC, we investigated the effect of KC-differentiation on CCL27 production and secretion in
monolayer and organotypic skin cultures using adult KC. In both experimental settings, cell-differ-
entiation strongly up-regulated CCL27 expression and secretion in KC. Together our findings sug-
gest that CCL27 plays a major role for the influx of memory T cells during skin development. In addi-
tion, we demonstrated that epidermal CCL27 secretion is strongly dependent on KC differentiation.
008
Calcitonin gene-related peptide (CGRP) and norepinephrine (NE) each bias Langerhans cell
(LC) antigen presentation towards generation of Th17 cells via actions on endothelial cells
(ECs)
RD Granstein, JA Wagner and W Ding Weill Cornell Medical College, New York, NY
We have recently found that the neuropeptide CGRP enhances production of IL-6, a cytokine impor-
tant for Th17 cell differentiation, by stimulated ECs and others have shown that NE also has this
effect. Thus, we asked whether CGRP alters the outcome of LC antigen presentation via effects on
bystander ECs. We used the transformed BALB/c EC line, bEnd.3, to examine this question. bEnd.3
cells (104/well) were plated in round-bottom 96-well plates in medium containing 100 nM CGRP,
10-5 M NE or medium alone. After 3 h, plates were washed x 4. Then, 104 LCs (obtained from BALB/c
epidermis by magnetic antibody separation) and 3x105 T cells from DO11.10 mice (BALB/c back-
ground) were added per well followed by addition of a chicken ovalbumin fragment (cOVA323-339)
to 10 μM. DO11.10 mice express transgenes such that their T cells recognize cOVA323-339. Other
wells were set-up without bEnd.3 cells. After 48 h of culture, cells were harvested and CD4+ T cells
analyzed by FACS. In cultures containing CGRP- or NE-treated bEnd.3 cells, T cells expressing intra-
cellular IL-17A were increased along with a decreased number of T cells expressing interferon gamma
(IFNγ). In replicate cultures, T cells were isolated and RNA extracted for quantitative RT-PCR. Treat-
ment of bEnd.3 cells with CGRP or NE resulted in enhanced mRNA expression for RORγt, IL-6 and
IL-17A with decreased expression of IFNγ and T-bet. Supernatants from these cultures assayed for
cytokine production by ELISA revealed that addition of CGRP- or NE-exposed bEnd.3 cells signifi-
cantly enhanced IL-6 and IL-17A production while significantly inhibiting IFNy production. Pre-
liminary experiments examining IL-6 and IL-17A production with primary murine dermal microvas-
cular ECs substituted for bEnd.3 cells yielded a similar result. As vessels within the dermis and
secondary lymphoid organs are associated with sensory and sympathetic nerves, these results sug-
gest a novel mechanism of regulation of cutaneous immunity by the nervous system.
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IFN-α abrogates the regulatory function of human CD4+CD25+FOXP+ Treg via MAPK/PDE4
pathway-regulated cAMP repression
V Raker,1 N Bacher,1 C Hofmann,1 E Graulich,1 M Schwenk,1 R Baumgrass,2 T Bopp,3 U Zechner,4
L Merten,4 C Becker1 and K Steinbrink1 1 University Medical Center, Dermatology, Mainz,
Germany, 2 German Rheumatism Research Centre (DRFZ), Berlin, Germany, 3 Johannes
Gutenberg-University, Institute of Immunology, Mainz, Germany and 4 University Medical
Center, Institute of Human Genetics, Mainz, Germany
IFN-α is well known for its anti-tumour activity and is therefore frequently used as a therapeutic
agent in a multitude of malignancies, including malignant melanoma and cutaneous lymphomas.
Previous reports in our group elucidated that IFN-α abolishes the suppressive function of human
regulatory T cells (Tregs) in vitro and in a xenogenic GvHD model in vivo. In the present study, we
found that IFN-α Tregs represses intracellular cAMP levels in Tregs. Blocking of cAMP degradation
by administration of the non-selective phosphodiesterase inhibitor IBMX or the PDE4 (highly expressed
in T Cells) specific inhibitor rolipram renewed cAMP levels accompanied by a restored suppressive
activity of the Tregs, indicating IFN-α as inhibitor of Treg functions by cAMP repression. Activation
of PDE4 is regulated by MAP kinases dependent pathways. Consequently, treatment with an Erk-
specific inhibitor completely normalized cAMP accumulation in IFN-α-treated Treg, demonstrating
that IFN-α activates an Erk-/PDE4 pathway resulting in cAMP reduction. In contrast, we did not
observe an altered methylation state of the TSDR (Treg specific demethylated region) within the
Foxp3-promoter, shown to be required for the stability of the FOXP3 expression, nor differences in
the cytokine production and anergic state of Tregs in the presence of IFN-α, excluding an impact
on the Treg differentiation program by the type I interferon. In conclusion, IFN-α acts as a potent
regulator of Treg activity affecting the suppressive function but not differentiation and stability of
human CD4+CD25high FOXP3+ Tregs.
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Accumulation of varicella zoster specific CD4+Foxp3+Tregs after cutaneous Ag challenge in
humans
D Sandhu,1,2 M Vukmanovic-Stejic,1 T Sobande,1 E Agius,1,2 G Ogg,3 MH Rustin2 and AN Akbar1
1 Infection and Immunity, UCL, London, United Kingdom, 2 Dermatology, Royal Free
Hospital, London, United Kingdom and 3 MRC Human Immunology Unit, University of
Oxford, Oxford, United Kingdom
Regulatory T cells play an important role in control of immune responses and have been found in
normal and inflamed human skin. The origin and antigen specificity of Foxp3+CD4+ regulatory T
cells is a question of some debate. We induced a DTH response by intradermal injection of vari-
cella zoster virus (VZV) skin test to investigate the relationship between VZV-specific CD4+ T cells
and CD4+Foxp3+ regulatory T cells (Tregs) during a memory immune response in humans in vivo.
CD4+Foxp3- and CD4+Foxp3+ T cells increase in parallel in the skin after VZV injection. The pro-
portion of CD4+Foxp3+ T cell remained constant throughout the response at around 10% of CD4+
T cells. VZV-specific CD4+ T cells were identified with a MHC class II tetramer or by intracellular
staining for either IFN-γ or IL-2 after antigen re-challenge in vitro. Using both methods, significant
increase in VZV-specific T cells was found at the site of skin challenge compared to blood of the
same individuals. Significant local proliferation was observed and peaked on day 7 after challenge
when around 20% of total and >50% of tetramer defined VZV-specific CD4+ T cells in the skin
expressed Ki67. CD4+Foxp3+ T cells that were found in the skin after VZV injection were
CD25hiCD127loCD39hi and did not secrete IFN-γ or IL-2 after antigenic re-stimulation. In addi-
tion, increased numbers of Tregs in the skin were associated with a significantly decreased inflam-
matory reaction, suggesting that these cells had inhibitory activity in vivo. Foxp3+ T cells that were
CD25hiCD127loCD39hi were also identified within the VZV tetramer population. In summary, our
data indicate that Ag- specific regulatory cells accumulate at sites of immune response in parallel
to the effector T cells of the same specificity. We hypothesise that CD4+Foxp3+ regulatory T cells
specific for foreign antigens may be derived from an antigen-specific memory population at the site
of an immune responses in vivo.
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TNF inhibitors directly target Th17 cells in psoriasis
T Shiga,1 K Sato,1 M Tarutani,1 S Kataoka2 and S Sano1 1 Dermatology, Kochi University,
Nankoku, Japan and 2 Science Research Center, Kochi University, Nankoku, Japan
TNF represents a key proinflammatory cytokine and plays a critical role in pathogenesis of psoria-
sis. Therefore, TNF inhibitors, such as infliximab, adalimumab and etenercept, show a great thera-
peutic efficacy on psoriatic lesions as well as patient’s quality of life. It has been thought that TNF
inhibitors attenuate psoriasis through inactivation of myeloid dendritic cells and subsequently the
IL-23/Th17 pathway or direct inhibiting effect on keratinocyte activation. However, the detailed
mechanism of TNF inhibitors still remains obscure. We experienced a patient with psoriatic ery-
throderma, who showed demarcated attenuation of lesions at the sites of adalimumab (ADA) injec-
tion. Immunohistochemical study using the lesional skin where ADA was subcutaneously adminis-
trated revealed that ADA predominantly bound to infiltrating T cells rather than epidermal
keratinocytes, dendritic cells or macrophages. This finding prompted us to investigate any direct
effect of TNF inhibitors on T cells. Peripheral blood T cells from normal healthy donor stimulated
in vitro with immobilized anti-CD3/CD28 in the presence of IL-1beta and IL-23 resulted in pro-
duction of IL-17A and TNF, indicating the Th17-skewing. In this experimental setting, inclusion of
etanercept significantly inhibited gene expression of IL-17A and production of IL-17A. Inhibition
of IL-17A production by etanercept was also observed in the peripheral blood T cells from psoria-
sis patients. Taken together, the present study suggests that TNF produced by Th17 cells is required,
in an autocrine fashion, for full maturation of Th17 cells. Therefore, TNF inhibitors directly target
Th17 cells, which play a crucial role in psoriasis pathophysiology.
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Early defect in cutaneous immune responses to varicella zoster virus challenge in old indi-
viduals
M Vukmanovic-Stejic,1 J Fuentes-Duculan,3 D Sandhu,1,2 T Sobande,1 M Suarez-Farinas,3
E Agius,1,2 H Mitsui,3 JG Krueger,3 MH Rustin2 and AN Akbar1 1 Infection and Immunity, UCL,
London, United Kingdom, 2 Dermatology, Royal Free Hospital, London, United Kingdom and
3 Investigative Dermatology, Rockefeller University, New York, NY
A marked increase in the susceptibility to skin infections and malignancies has been observed in
older humans indicating that cutaneous immunity becomes defective with age. As Varicella Zoster
Virus (VZV) often reactivates in the old individuals causing shingles we studied the kinetics of the
cutaneous response in young and old subjects (<40 years old and >65 years old respectively) who
were challenged with a VZV skin test antigen. We found that old individuals have reduced clinical
responses to intradermal challenge VZV despite showing equivalent PBMC proliferative responses
to VZV in vitro. In young individuals both CD4+ and CD8+ T cells accumulated at the site of VZV
injection, peaking at day 7, whereas T cell accumulation was significantly reduced in the old, cor-
relating with the reduced clinical score. There was also significant reduction in the accumulation
of inflammatory CD11c+ DCs and CD163+ macrophages in the old individuals. The expression of
E-selectin, VCAM and ICAM-1 was also significantly reduced in the old individuals which may con-
tribute to the observed lack of cellular infiltrate. There was no difference between young and old
individuals in the numbers of resident T cells, DCs and macrophages in normal skin or at 6hrs after
VZV challenge. There was however an increase in proportion of Foxp3+CD4+ cells in the normal
skin of old individuals and this inversely correlates with the magnitude of the clinical response. To
understand the mechanism responsible for lack of responsiveness in the old skin we examined the
transcriptome of young and old skin after VZV challenge. In agreement with the cellular data, reduced
inflammatory signature was observed in the old skin suggesting inadequate early activation in
response to VZV challenge.
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Imiquimod with dacarbazine diferentiates B7H1-expressing MDSC into IFN-γ producing
macrophages in B16F10 melanoma
T Fujimura,1 Y Kambayashi,1 S Furudate,1 N Ishii2 and S Aiba1 1 Department of Dermatology,
Tohoku University, Graduate School of Medicine, Sendai, Japan and 2 Department of
Immunology, Tohoku University, Graduate School of Medicine, Sendai, Japan
Myeloid-derived suppressor cells (MDSC) comprise a heterogeneous population of cells (CD11b+,
Gr-1+) that can be found in tumor-bearing hosts. We previously reported that MDSCs suppress the
activity of T cells together with Tregs through B7H1-mediated pathways. To further investigate the
suppressive function of B7H1 in melanoma, first we subcutaneously injected mice with 2 x 105
B16F10, administered several doses of B7H1Ab and then assessed the suppressive capacities of
B7H1Ab in vivo. The administration of B7H1 Ab significantly suppressed the B16F10 melanoma
growth in a dose-dependent manner. FACS analysis revealed that the blocking of B7H1 in vivo
induced CD69 expression on CD4 and CD8 cells in the tumor-bearing host. To analyze the sup-
pressive function of MDSC, we isolated CD11b+ cells and co-cultivated them with syngeneic CD4+
T cells and allogeneic BMDCs. Actually, splenic, B7H1 highly expressing CD11b+ cells suppress
the proliferation of CD4+ T cells. Next, to develop B7H1 targeting immunotherapy, we set up ther-
apeutic models for B16F10 melanoma using imiquimod (IQM) and dacarbazine (Dac). The admin-
istration of IQM with Dac significantly suppressed the B16F10 melanoma growth. Moreover, we
investigated the mechanisms of the suppressive function of this immuno/chemotherapy, especially
focusing on B7H1-expressing MDSC. Interestingly, IQM/Dac therapy induced the differentiation of
IL-10 producing, B7H1 expressing MDSC into IFN-γ producing macrophages, which might be related
to the suppression of melanoma growth. Our results suggest that splenic CD11b+ cells highly express
B7H regulatory molecules, and IQM/ Dac therapy differentiates these MDSC into immunogenic
macrophages.
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Involvement of IL17 positive T cells in acne vulgaris
B Bertino,1 I Carlavan,1 M Roquet,1 B Mehul,1 S Déret,1 P Grundt,1 P Reiniche,1 F Joly,1
B Gauthier,1 J Aubert,1 A Jomard,1 P Martel,1 C Marty,1 U Blume-Peytavi2 and JJ Voegel1 1
Galderma R&D, Sophia Antipolis, France and 2 Department of Dermatology, Charité-
Universitätsmedizin, Berlin, Germany
To characterize the inflammatory infiltrates of acne vulgaris lesions, and to confirm previous tran-
scriptomic results indicating the involvement of Th17 cells in the pathogenic process of acne, lesional
and non-lesional human skin biopsies from twelve patients with inflammatory acne vulgaris were
analyzed. qRT-PCR and Luminex assays were performed for mRNA and protein analysis, respec-
tively. In parallel, histology and immunohistochemistry were performed to document the morphology
of the lesions and to detect IL17-positive T cells in the inflammatory infiltrates. At the mRNA level,
the most representative cytokines secreted by Th17 cells, including IL17A, IL17F and IL26, were
found to be up-regulated in acne lesions. Furthermore, the protein levels of cytokines characteriz-
ing Th17 cells, such as IL6, IL17A, IL17F, IL22, IL23A, CCL20 and TNF, were up-regulated in lesional
skin versus non-lesional skin (p<0.05). Histological examination was consistent with the diagnosis
of acne vulgaris, most lesional biopsies showing perifolliculitis/folliculitis up to ruptured follicle
walls. Infiltrates were more important in lesional biopsies when compared to non-lesional areas
(10/12 and 0/12 patients with a score of slight to marked, respectively). IL17 positive cells were
found to be correlated with the presence of infiltrates. IL17 positive cells were mainly CD3 positive
cells in lesional as well as non-lesional samples (87+/- 14 % and 90% +/- 11 %, respectively). Our
results identify acne vulgaris as an inflammatory disorder mediated among other factors by a Th17
response. These findings indicate new possibilities to target the inflammatory response in acne vul-
garis.
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Expression of IL-23/Th17 pathway in early inflamed acne lesions
H Kelhälä,1 R Palatsi,1 S Lehtimäki,2 N Fyhrquist,2 M Kallioinen,3 M Kubin,1 K Tasanen,1
H Alenius2 and A Lauerma4 1 Department of Dermatology, University of Oulu, Oulu, Finland,
2 Control of Hypersensitivy Diseases, Finnish Institute of Occupational Health, Helsinki,
Finland, 3 Department of Pathology, University of Oulu, Oulu, Finland and 4 Department of
Dermatology, University of Helsinki, Helsinki, Finland
Acne vulgaris is a common disease characterized by androgen dependence, follicular hyperker-
atosis, increased sebum excretion, colonization with P. acnes and inflammatory events. The for-
mation of microcomedone is preceded by mononuclear, mainly CD4 positive T-cell infiltrates and
macrophages. We examined the biopsies obtained from early inflamed lesions and non-lesional
skin of acne patients (n=20) and, as control, lesional and non-lesional skin of psoriasis patients (n=9)
by RT-PCR and immunohistochemistry. RT- PCR showed significant similarities between cytokine
profiles in lesions of acne and psoriasis. We found increased expression of Th17 cytokines: IL-17A
increase was 22.7-fold (p< 0.001) in lesions of acne compared to the non-lesional skin and 20.1-
fold (p<0.001) in psoriasis in lesional compared to non-lesional skin. IL-23p19 increased 3.1-fold
in acne and 9.2-fold in psoriasis, p<0.001 in both diseases. Also Th1 markers CXCR3, T-bet and INF-
gamma were significantly increased in acne and psoriasis compared to non-lesional skin. Foxp3
elevation was 2.5 fold in acne and 4.1 fold in psoriasis (p<0.001 in both) and also TGF-beta and
IL-10 increased very significantly. IL-17 is known to be a potent inducer of antimicrobial peptides
and chemotaxis of neutrophils. Pro-inflammatory cytokine IL-8, IL-1beta and TNF-alpha were sig-
nificantly increased as well as the antimicrobial peptides S100A7, S100A9, LCN2, hBD2, hBD3
and hCAP18. Immunohistochemistry revealed IL-17A and Foxp3 positive cells. Naturally the local-
ization of the positive cells was different in acne compared to psoriasis. This is the first study link-
ing Th17 and Treg cells to early inflammatory events in acne lesions and shows similarities in cytokine
profiles in acne and psoriasis.
016
A new model for evaluating topical treatments for Th17 mediated diseases using ex vivo human
skin
H Aloor, C Peredo, H Hofland, SH Smith, J Therrien and J Cote-Sierra Center for Skin Biology,
Stiefel, a GSK company, Research Triangle Park, NC
The activation of skin resident T cells and subsequent production of pro-inflammatory cytokines IL-
17 and IL-22 are pivotal steps in the development and progression of autoimmune skin disease, such
as psoriasis. Although several rodent models exist, none completely recapitulates human disease.
Animal models also present a challenge for target validation when investigating effects of topical
treatment because the properties of rodent and human skin differ. A novel tissue-based assay that
focuses on T cell-mediated immune responses within the skin was developed. Resident T cells are
activated in situ in freshly excised healthy human skin, resulting in Th17 differentiation, and signif-
icant cytokine production, including IL-17 and IL-22. Importantly, we show that T lymphocytes
remain inside the dermal tissue throughout culture as stimulation-dependent cytokine expression
is observed by PCR for up to 6 days post stimulation. After 4 days of stimulation under Th17-polar-
izing conditions, epidermal ballooning degeneration was observed. The data suggest that expres-
sion of IL-17 and IL-22 in the tissue caused the tissue damage. Indeed, similar degeneration of the
epidermis was observed when recombinant IL-17A and IL-22 protein was added to the culture
medium, in the absence of overt T cell stimulation. IL-17 production is highly dependent on the
transcription factor RORgt. Therefore, the model was further validated using specific small mole-
cule inhibitors of RORg. Pretreatment of human skin explant cultures with RORg inhibitors abro-
gated activation-induced il-17a and il-17f message expression, but not il-22. Our data show that T
cells can be activated in situ in healthy skin explant cultures, which provide an ideal model system
for assessing target engagement of immunomodulatory therapeutic compounds intended for topi-
cal use.
014
Induction of CD163+ M2 macrophages in the lesional skin of eosinophilic pustular folliculi-
tis
S Furudate, T Fujimura, Y Kambayashi and S Aiba Department of Dermatology, Tohoku
University Graduate School of Medicine, Sendai, Japan
Eosinophilic pustular folliculitis (EPF) is a rare dermatitis of unknown etiology that is characterized
by recurrent clusters of pruritic, follicular, sterile papules and pustules over the face, trunk and upper
extremities. Recent reports suggested that EPF is often accompanied by peripheral blood eosinophilia,
and a Th2 cytokine-dominant condition has been postulated as one of the underlying mechanisms.
More recently, it was reported that Jumonji domain containing-3 (Jmjd3) is essential for M2
macrophage polarization and targeting transcription factor interferon-regulatory factor 4 (Irf4), which
has been shown to be involved in Th2 polarization. Accordingly, the purpose of this study was to
elucidate the involvement of M2 macrophages and Th2 related signals and cytokines in EPF. We
employed immunohistochemical staining for CD163, pSTAT6, IL-10 and Foxp3 to 5 cases of clas-
sic, non-immunosuppression-associated EPF. Interestingly, immunohistochemical staining revealed
dense infiltration of CD163+ M2 macrophages in the interstitial area of the dermis and perifollicu-
lar areas of the lesional skin. In addition, the pSTAT6-expressing infiltrating cells and IL-10 pro-
ducing cells suggested the contribution of Th2 cells to the establishment of EPF. In parallel with M2
macrophages, Foxp3+ Tregs were also prominent in the interstitial area of the dermis and perifol-
licular areas of the lesional skin. Our case might suggest possible mechanisms in the development
of EPF through CD163+ M2 macrophages and Th2 pathways.
018
Development of a novel immunotherapy for melanoma which inhibits interaction between
CD155 on melanoma cells and TIGIT on activated CTL
T Inozume,1 J Furuta,1 K Harada,1 T Yaguchi,2 Y Kawakami2 and S Shimada1 1 Dermatology,
University of Yamanashi, Yamanashi, Japan and 2 Division of Cellular Signaling, Institute for
Advanced Medical Research, Keio University, Tokyo, Japan
Durable complete responses observed in metastatic melanoma patients who received anti-CTLA-4
or anti-PD-1 antibody clearly show that blockade for T cell-suppressive molecules is a promising
strategy to reject melanoma tumors. We have identified some novel, IFNγ inducible T cell-sup-
pressive molecules expressed on melanoma cells like PD-L1, by gene expression profiling of
melanoma cells. Also we have established the experimental system to test the impact of the candi-
date molecules on anti-tumor CTL response in vitro and in vivo, using highly antigen specific arti-
ficial CTLs and melanoma cells transfected with the candidate genes. CD155 is one of the candi-
date molecules, which is reported as a co-stimulatory molecule expressed by APCs and tumor
cells. TIGIT is one of the receptor for CD155 expressed by activated T cells that suppresses activa-
tion of T cells. CD155 was expressed by human melanoma cell lines (6/6) and up-regulated by IFNγ.
Also, it was expressed on melanoma tissues (5/5). Activation of the melanoma specific CTLs assessed
by cytokine release was significantly suppressed by CD155 over-expressed on melanoma cells, and
the suppressive effect was comparable to that of PD-L1 over expressed on melanoma cells. Also we
could confirm that blockade for CD155-TIGIT interaction could enhance the activation of melanoma
reactive CTLs on encountering CD155 expressing melanoma cells. Moreover, additive effect of
CD155-TIGIT blockade and PD-1-PD-L1 blockade was observed in vitro. This is the first report show-
ing the suppressive effect of CD155 over-expressed on melanoma cells in anti-melanoma CTL-
response. In addition to blockade for CTLA-4-B7 and PD-1-PD-L1 engagement, blockade for CD155-
TIGIT engagement is another immunotherapy to induce strong anti-melanoma immuno-response.
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Interferon-γ and tumor necrosis factor control human cancer by induction of cellular senes-
cence
T Wieder,1 H Braumüller,1 K Schilbach,2 K Braungart,1 F Essmann,3 E Brenner,1 S Weidemann,1
R Handgretinger,2 K Schulze-Osthoff3 and M Röcken1 1 Dermatology, University of Tübingen,
Tübingen, Germany, 2 General Pediatrics, University of Tübingen, Tübingen, Germany and 3
Biochemistry, University of Tübingen, Tübingen, Germany
Recent studies from targeted cancer immunotherapies show that adaptive immunity can control
human cancer. Cancer control eventually occurs in the absence of cytotoxic effects, e.g. induction
of apoptosis or perforin/granzyme B-mediated cytotoxicity. Interestingly, we and others found that
tumor-specific, interferon-γ (IFN-γ)- and tumor necrosis factor (TNF)-producing T helper 1 (Th1) cells
arrest cancer growth, but the underlying mechanisms were unknown. As MHC class II-restricted
Th1 cells can not directly interact with most cancer cells, we investigated the effect of soluble Th1
cytokines on human cancer cells. Proliferation was measured by BrdU incorporation, cell cycle reg-
ulation by Western blot analysis of the p16Ink4a/Rb signalling pathway, and senescence induction
by an in vitro growth arrest assay. Treatment of A204 rhabdomyosarcoma cells with IFN-γ and TNF
for 72 h strongly suppressed their proliferation. Growth inhibition was accompanied by severe
hypophosphorylation of Rb at Ser795 indicating that the combined action of the two cytokines drives
cancer cells into senescence. Indeed, the cell cycle arrest was permanent, as the cancer cells did
not restart growing after IFN-γ/TNF removal. To study whether cytokine-induced senescence could
be of broader relevance, we screened 11 human cancer cell lines for permanent growth arrest. All
cancer cell types expressed the relevant IFN-γ and TNF receptors, and responded to challenge with
the cytokines. Moreover, 55 % of the cell lines were permanently growth arrested. IFN-γ/TNF also
induced senescence in primary human rhabdomyosarcoma and melanoma cells. Taken together,
our data show that Th1 cytokines control human cancer by inducing irreversible growth arrest. Thus,
cytokine-induced senescence can be considered as an intergral part of tumor surveillance by the
immune system, and opens perspectives for innovative immunotherapeutic approaches.
020
Casein kinase II regulates the intracellular routing of the dendritic cell receptor DEC205 to
MHC class II+ compartments and it’s recycling to the cell surface
RM Koch, S Ring, A Enk and K Mahnke Ruprecht Karls University, Heidelberg, Germany
The intracellular trafficking of the dendritic cell (DC) antigen receptor DEC205 is guided by an intra-
cellular domain, that routes antigens into MHC-II+ compartments. This domain contains a putative
casein kinase II (CKII) phosphorylation site and we asked whether this site is involved in intracel-
lular targeting of DEC205 to late endosomes (LE). We generated fusionreceptors containing the
HuIgG-binding, extracellular domain of human CD16 and the intracellular DEC205 domain
(CD16:DEC) and established stably transfected the antigen presenting cell line DCEK. In pulse –
chase experiments we incubated the celllines with HuIgG on ice for 1h, followed by a chase at 37°C
for 20 to 60 min. We show, that CD16:DEC transfected cells bind and endocytose HuIgG effi-
ciently, and after 30 min many vesicles start to fuse with Rab7+ LE. These vesicles were also posi-
tive for CKII indicating a role of CKII in DEC205 trafficking. When we applied the CKII inhibitor
TBB, endocytosis of HuIgG by CD16:DEC was not affected, but instead the recycling of the DEC
receptor from LE to the cell surface was blocked. Moreover, inhibition of CKII also lead to a pro-
longed half-life of endocytosed HuIgG within LE and in antigen presentation assays with HuIgG-
specifc T-cells, TBB-treated DCEK cells induced reduced T cell proliferation as compared to con-
trols. Finally we confirmed our results by deleting the CKII site in chimeric CD16:DEC receptors by
site-directed mutagenesis yielding CD16:DECdelCKII receptors. These receptors accumulated in
LAMP1/Rab7+ LE and showed severely reduced expression on the cell surface. Thus this data indi-
cate that phosphorylation of the intracellular domain of the DEC205 antigenreceptor by the CKII is
crucial for the transport of its ligands beyond the LE to MHC class II+ compartments and for the
recycling of the DEC205 receptor back to the cell surface. Further investigations of this pathway
may explain the efficiency of antigen targeting to DC in vivo.
021
The amino acid sequence EDExxL in the intracellular domain of the DEC205 receptor medi-
ates antigen uptake in dendritic cells by interaction with adaptin-2
S Ring, A Pushkarevskaya, RM Koch, A Enk and K Mahnke Ruprecht Karls University,
Heidelberg, Germany
The antigen receptor DEC205 mediates efficient endocytosis in dendritic cells (DC). Its intracellu-
lar domain harbours a putative targeting sequence (single letter code: EDExxL), which is highly
homolog to a DExxxL sequence previously shown to route lipoprotein receptors to lysosomes. To
analyze the function of this motive in DEC205, we generated fusion receptors containing the IgG-
binding extracellular domain of human CD16 and the murine intracellular DEC205 domain (WT-
DEC:CD16). By site directed mutagenesis we also mutated the EDExxL sequence to AAAxxL (AAA-
DEC:CD16). Stably transfected cell lines of DCEK cells were established. When we analyzed the
endocytosis of the ligand human IgG (hIgG) in the two different cell lines we found that WT-DEC:CD16
cells took up the ligand completely within 30 min, whereas AAA-DEC:CD16 endocytosed only 10%
of surface bound hIgG. When analyzing the distribution of the DEC:CD16 receptors in steady state,
i.e. without incubation with hIgG, we found that WT-DEC:CD16 receptors were present in vesicles
within the cells, whereas AAA-DEC:CD16 receptors remained mostly close to the cell surface. Analy-
sis of the intracellular transport of hIgG showed that in WT-DEC:CD16 hIgG moved through early
endosomes (EE; Rab5+/EEA1+; 10 min after uptake) to late endosomes (LE; Rab7+; 30 min after
uptake). In contrast, AAA-DEC:CD16 molecules remained mostly on the surface and only partly
entered the EE. When analyzing the recruitment of adapter molecules to DEC:CD16 receptors we
found colocalisation of adaptin-2 with WT-DEC:CD16 but not with AAA-DEC:CD16. These results
could further be supported by co-immunoprecipitation of adaptin-2 with WT-DEC:CD16. Thus these
data indicate that the intracellular targeting of the antigenreceptor DEC205 is initiated by the inter-
action of adaptin-2 with an EDExxL motive in it’s intracellular domain. This interaction is crucial for
the effective presentation of antigens by DC and may therefore influence the effective activation of
T cells by MHC-peptide complexes.
022
GILT expression in medullary thymic epithelial cells is required for presentation of tissue-spe-
cific self antigens and deletion of autoreactive T cells
MP Rausch,1 TC Metzger,2 MS Anderson2 and KT Hastings1 1 University of Arizona College of
Medicine, Phoenix, AZ and 2 University of California, San Francisco, CA
Clonal deletion of thymocytes with a high avidity interaction for self-peptide:MHC complexes is
critical for the maintenance of tolerance and prevention of autoimmunity. We have previously shown
that gamma-interferon-inducible lysosomal thiol reductase (GILT) is required for thymic deletion of
CD4+ T cells specific for the self and melanoma antigen, tyrosinase-related protein 1 (TRP1). To
define GILT’s role in the maintenance of central tolerance, we show that GILT expression is enriched
in thymic antigen presenting cells (APCs) capable of mediating deletion, namely medullary thymic
epithelial cells (TECs) and thymic dendritic cells. TRP1 expression is restricted to medullary TECs,
consistent with Aire-mediated transcriptional regulation. GILT facilitates the MHC class II-restricted
presentation of endogenous TRP1 by pooled thymic APCs (TECs and bone marrow-derived APCs).
Using bone marrow chimeras, we demonstrate that TRP1-specific T cells are deleted in chimeras in
which GILT is expressed in both TECs and bone marrow-derived APCs or in which GILT expression
is restricted to TECs, demonstrating that GILT expression in TECs is sufficient for deletion of TRP1-
specific thymocytes. In contrast, a large number of TRP1-specific T cells develop in chimeras which
lack GILT expression in both TECs and bone marrow-derived APCs. Chimeras in which GILT expres-
sion is limited to the bone marrow-derived APCs have intermediate levels of TRP1-specific T cells,
demonstrating that GILT expression in TECs is required for efficient deletion of TRP1-specific thy-
mocytes. These findings suggest that GILT operates in mTECs to facilitate the presentation of tissue-
specific self antigens and promote deletion of autoreactive T cells.
023
Pathodynamics of CD8 T-cell trafficking in a murine model of graft-versus-host disease (GvHD),
implicate the CXCR3 axis as a crucial organizer of cutaneous inflammation and injury
VA Villarroel, N Okiyama, G Tsuji, J Linton and SI Katz Derm Branch, CCR, NCI, NIH, Beth, MD
Though the skin is the most commonly affected organ in GvHD, the mechanisms underlying its
development are incompletely characterized. To study early molecular processes, qRT-PCR was used
to profile epidermal chemokine mRNA expression in a model of GVHD-like disease where K14-
mOVA mice containing a self-antigen, ovalbumin (OVA), develop skin/mucosal inflammation and
weight loss following adoptive transfer of OT-I (OVA-specific) CD8+ T cells. qRT-PCR of epidermal
mRNA demonstrated marked upregulation of CXCL9 and CXCL10, IFN-γ inducible ligands sharing
a common CXCR3 receptor, with 10 fold induction of CXCL10 mRNA detectable as early as 2 days
post-OT-I transfer (dpt) and peak induction of CXCL9 and CXCL10 mRNA at 100 and 150-fold,
respectively at 5 dpt. At 2 to 4 dpt, qRT-PCR of skin-draining lymph nodes (SDLN) revealed early
upregulation of CXCL9 and CXCL10 mRNA from between 20-40 fold vs. untreated K14-mOVA
SDLN mRNA. FACS analysis of the SDLN at 5 dpt demonstrated that greater than 95% of OT-I cells
expressed CXCR3 while only 20% of recipient CD8 T-cells expressed CXCR3 suggesting upregula-
tion of CXCR3 might facilitate trafficking to highly inflamed foci. Coincident with peak epidermal
CXCL9/10 mRNA expression, OT-I cells were detected in the skin as early as 5 dpt via IF and pro-
gressive infiltration continued, persisting beyond 13 dpt. FACS of total skin suspensions showed
that OT-I cells accounted for 31.8% of total skin lymphocytes. The kinetics of chemokine and
receptor expression suggested that CXCL9/10 may accelerate migration of Ag-specific T-cells to anti-
gen-replete tissues orchestrating target organ damage. Transfer of OT-I/CXCR3KO cells into K14-
mOVA mice resulted in unaltered weight loss, but markedly attenuated skin disease vs. wild-type
OT-I transferred K14-mOVA controls. These findings indicate that, in GvHD, epidermis expresses
CXCL9 and 10 and attracts CXCR3+ T cells and suggest that targeting the CXCR3 axis may have
clinical utility in GvHD and related skin diseases.
024
Characterization of house dust mite specific T cells in atopic dermatitis at the single cell
level
LM Rösner,1 A Heratizadeh,1 C Hennig,2 G Hansen,2 P Moingeon3 and T Werfel1 1 Department
of Dermatology and Allergy, Division of Immundermatology and Allergy Research, Hannover
Medical School, Hannover, Germany, 2 Department of Pediatric Immunology, Allergology and
Pneumology, Hannover Medical School, Hannover, Germany and 3 Stallergenes SA, Antony,
France
CD4+ Tetramer-staining and T cell cloning of house dust mite (HDM) specific T cells have been
reported recently and are described as central and effector memory T cells producing Th1, Th2 and
Th17 cytokines in patients with allergic asthma. Here, we used the novel technique Chipcytome-
try to perform deep characterization of Der p 1 and Der p 2-tetramer-binding T cells at single cell
level in blood of patients with atopic dermatitis (AD). By subsequent fluorescence staining/bleach-
ing steps, immobilized cells are analyzed by a comprehensive marker set, providing information
about the T cell subset. Furthermore, the staining is documented in a microscopy picture, allowing
a qualitative analysis and discarding artefacts, which may influence experiments with low cell num-
bers significantly. In this approach, every single tetramer-positive T cell was stained with a deep-
characterization marker panel including CD4, CD8, CD14, CD19, CRTh2, CCR-6, IL-18R, CD27,
CD45R0, CD45RA and a vital stain. By this means, we describe house dust mite-specific memory
T cells (Tetramer+/CD45R0+) in the peripheral blood of sensitized patients with AD. We confirm
observations from asthma research and describe HDM-specific T cells of the Th2, Th17 and Th2/Th17
phenotype as detected via surface markers. Furthermore we can show that these cells are termi-
nally differentiated (CD27-) and therefore most likely contribute to the disease in AD-patients.
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025
Anaphylaxis triggered by innate immune signals as co-factors is mediated by basophils inde-
pendent of IgE
F Wölbing,1 S Kaesler,1 W Kempf,1 B Siraskar,2 P Eckstein,1 M Köberle,1 Y Skabytska,1 F Lang,2
P Yu,3 D Voehringer,4 M Röcken1 and T Biedermann1 1 Department of Dermatology, Eberhard
Karls University, Tübingen, Germany, 2 Department of Physiology, Eberhard Karls University,
Tübingen, Germany, 3 Institute of Immunology, Philipps-University, Marburg, Germany and 4
Department of Infection Biology, Friedrich-Alexander-University, Erlangen, Germany
Anaphylaxis is classically induced by cross linking of IgE bound to FcεRI on mast cell (MC) or basophil
surfaces. Alternatively, IgG antibodies can also initiate anaphylaxis. Certain co- or augmentation
factors, as best documented for wheat dependent exercise induced anaphylaxis, alcohol consumption
or infections, can augment anaphylaxis. To understand how infections trigger anaphylaxis we sen-
sitized mice with Ovalbumine (OVA) and mimicked infection by pretreatment with different pathogen
associated molecular patterns (PAMPs) prior to challenge. Pretreatment triggers full-blown ana-
phylaxis as measured by significantly decreased core body temperature, significant reduction in sys-
tolic blood pressure and an increase in serum histamine levels. Experiments using basophil depleted
or basophil deficient and mast-cell-deficient Kitw-sh/w-sh mice showed that PAMP triggered ana-
phylaxis is MC independent but basophil dependent. Most interestingly, IgE-knock-in mice, in which
the exon for IgG1 is substituted by an exon coding for IgE leading to IgG1 deficiency and IgE over-
production, do not develop PAMP dependent anapyhlaxis. Finally, to understand how PAMPs act
on basophils triggering IgG1 dependent activation, we generated knock-out mice deficient in the
pathogen recognition receptors (PRR) TLR2 and NOD2, allowing the analysis of the PAMP PGN. In
those mice PAMP dependent anaphylaxis was completely absent. In summary, we prove that PAMPs
act as co-factors modulating the onset of IgG1 and basophil dependent anaphylaxis via binding to
PRR. These data show for the first time a clinical relevance of IgE independent basophil-mediated
anaphylaxis. This is of major clinical importance for the diagnosis and management of patients
with anaphylaxis and may help to develop to new therapeutic strategies.
027
The specific IgE against sweat antigen in sera of patients with allergic diseases
M Hiragun,1 K Ishii,1 T Hiragun,1,2 H Suzuki,3 Y Yanase,1 S Mihara1 and M Hide1 1 Department
of Dermatology, Integrated Health Sciences, Institute of Biomedical and Health
Sciences,Hiroshima University, Hiroshima, Japan, 2 Natural Science Center for Basic Research
and Development, Hiroshima University, Hiroshima, Japan and 3 Faculty of Human Science,
Hiroshima Bunkyo Women’s University, Hiroshima, Japan
Background: We previously demonstrated that the semi-purified human sweat antigen (QRX) causes
positive skin tests and histamine release from basophils via specific IgE in patients with atopic der-
matitis (AD). In the last 37th JSID, we reported that the method of enzyme-linked immunosorbent
assay (ELISA) to measure specific IgE against QRX by using sera of patients with AD. In this study,
we examined the specific IgE against QRX in patients with other allergic diseases. Methods: QRX
was prepared by anion-exchange and reverse-phase column chromatography from pooled sweat
samples of healthy donors. Sera of patients with AD (n=63), cholinergic urticaria (ChU) (n=27), aller-
gic rhinitis (AR) (n=11), asthma (n=15), and sera of normal controls (NC) (n=23) were used in this
study. QRX was immobilized onto the wells of 96-well plates which were pre-coated with mono-
clonal IgG1-kappa against QRX. QRX-specific IgE in sera were bound to the immobilized QRX and
detected by horseradish-conjugated anti-human IgE and substrates. To quantify the amount of IgE,
the standard serum was created by pooling sera of 20 patients with AD whose basophils release
histamine in response to QRX. Results: Positive rate of specific IgE against sweat antigen in sera of
NC and patients with AD, ChU, AR, and Asthma are 26.1%, 71.4%, 55.6%, 63.6%, and 13.3%,
respectively. The levels of the IgE against QRX in sera of patients with severe AD were significantly
higher than those with mild AD. Conclusions: Quantification of specific IgE against QRX by ELISA
is useful not only to diagnose sweat allergy but also to evaluate disease severity in patients with AD.
Moreover, patients with ChU and AR have significantly higher positive rates of specific IgE against
QRX than NC.
029
Therapeutic potential of B and T lymphocyte attenuator expressed on CD8+ T cells for con-
tact hypersensitivity
D Nakagomi,1,2 K Suzuki,1 H Matsue,2 S Shimada3 and H Nakajima1 1 Allergy and Clinical
Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan, 2 Dermatology,
Graduate School of Medicine, Chiba University, Chiba, Japan and 3 Dermatology, Graduate
School of Medicine, Yamanashi University, Yamanashi, Japan
Background: In the past decade, mechanisms underlying allergic contact dermatitis have been inten-
sively investigated by using contact hypersensitivity (CHS) models in mice. However, the regulatory
mechanisms, which could be applicable for the treatment of allergic contact dermatitis, are still
largely unknown. Objective: To determine the roles of B and T lymphocyte attenuator (BTLA), a
CD28 family co-inhibitory receptor, in hapten-induced CHS reaction and examine the therapeutic
potential of an agonistic agent for BTLA on CHS reaction. Methods: BTLA-deficient (BTLA-/-) mice
and littermate wild-type (WT) mice were subjected to dinitrofluorobenzene (DNFB)-induced CHS
reaction. SCID mice injected with CD4+ T cells and CD8+ T cells from either WT mice or BTLA-/-
mice were subjected to CHS reaction. In addition, the effects of an agonistic anti-BTLA antibody
(6A6) on CHS reaction were evaluated. Results: BTLA-/- mice showed enhanced DNFB-induced
CHS reaction and increased IFN-γ production of CD8+ T cells as compared to WT mice. SCID
mice injected with WT CD4+ T cells and BTLA-/- CD8+ T cells showed enhanced CHS reaction as
compared to those injected with WT CD4+ T cells and WT CD8+ T cells. On the other hand, SCID
mice injected with BTLA-/- CD4+ T cells and WT CD8+ T cells exhibited similar CHS reaction to
those injected with WT CD4+ T cells and WT CD8+ T cells. Moreover, in vivo injection of 6A6 sup-
pressed DNFB-induced CHS reaction and IFN-γ production of CD8+ T cells. Conclusion: Stimula-
tion of BTLA with the agonistic anti-BTLA antibody may have therapeutic potential for CHS reac-
tion.
028
Identification of inducible lymph node-like structures in the skin: A key site to elicit contact
hypersensitivity responses
Y Natsuaki,1,2 G Egawa,1 S Nakamizo,1 S Hanakawa,1 T Hashimoto,2 Y Miyachi1 and
K Kabashima1 1 Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
and 2 Dermatology, Kurume University School of Medicine, Kurume, Japan
Epicutaneous sensitization is established in the draining lymph nodes where dendritic cells (DCs)
and T cells colocalize, however it remains unclear how the elicitation of cutaneous immune responses
are efficiently induced in the skin. To address this issue, we used murine contact hypersensitivity
(CHS) as a delayed-type hypersensitivity model, which consists of the sensitization and elicitation
phases. Initially, using CD11c-DTR (diphtheria toxin receptor) and Langerin-DTR knockin mice,
we identified dermal DCs (dDCs), but not Langerhans cells, as a responsible DC subset for elicita-
tion of CHS. This finding suggests that the dermis is the primary site for elicitation. Next, we visu-
alized the dynamics of dDCs and memory T cells in the elicitation phase of CHS using two-photon
microscopy, and found that dDCs accumulated in perivascular areas and interacted with skin-infil-
trating memory T cells for several hours. This immunological synapse-like interaction was essential
for memory T cells proliferation in situ in an antigen and integrin LFA-1 dependent manners. Intrigu-
ingly, dDC accumulation was abrogated by depletion of macrophages by means of LysM-DTR
chimeric mice. Taken together, we have demonstrated for the first time that lymph node-like struc-
tures are induced at the post capillary venules in the elicitation phase of CHS, and that this com-
plex consists of perivascular macrophages, dDCs and memory T cells which interact via immuno-
logical synapse formation to induce efficient cutaneous acquired immune responses.
026
Nanpoarticle based intradermal formulation targeting DC skin subsets to increase vaccine
potency against HIV-1
JP Mitchell,1 S Hirosue,2 G Dolton,1 AK Sewell,1 JA Hubbell,2 F Blanchet1 and V Piguet1 1 Cardiff
University, Cardiff, United Kingdom and 2 EPFL, Lausanne, Switzerland
Delivery of vaccine formulations into the dermis using antigen-coated micro needles is a promis-
ing approach due to the efficient antigen delivery and safety. There is evidence that intradermal
delivery of vaccines is more effective than alternative routes, such as intramuscular. Vaccines pre-
venting HIV infection are still lacking, effective prevention against this pathogen would represent
a major advance in global health. The aim of this study is to evaluate the capacity of a new intra-
dermal vaccine formulation using virus specific antigens conjugated to polypropylene sulfide nanopar-
ticles (PPS-NP) to induce immunity against HIV infection. We tested the efficacy of PPS-NP formu-
lations on primary Dendritic Cells (DC) including skin DC subsets. Firstly we used Monocyte-derived
DC (MDDC) for preliminary developmental experiments. We further investigated these aspects on
plasmacytoid (pDC) and myeloid (myDC) DC from the peripheral blood as well as on langerhans
cells (LC) and dermal DC (dDC) from human skin samples. Primary DC subsets were incubated with
the PPS-NP and PPS-NP-p24 formulations in the presence and absence of TLR agonists before analy-
sis for cell viability, maturation and cytokine production. From these preliminary results we can con-
clude that the PPS-NP formulation is non-toxic to the DC and does not affect DC maturation or TNF-
α induction by TLR agonists. Antigen presentation experiments indicate that PPS-NP-p24 is
preferentially presented by DCs over unconjugated p24 protein. These results are in contrast to
antigen presentation using B cells as antigen presenting cells (APC). We have determined that
delivery of the HIV antigen p24 via PPS-NP is non-toxic to cells in vitro. The nanoparticle formu-
lation does not affect the function of the antigen presenting cells with regards to response to stim-
ulus. The formulation may however be more efficiently presented in DC subsets over p24 antigen
alone. In conclusion nanoparticle based vaccines represent a potential avenue to increase delivery
of antigens in the skin.
030
IL-6 and IL-10 secreted from B16 melanoma cells initiate the differentiation of CD4+/ CD8+
T cells in cancer microenvironment: Inhibition of STAT3-signaling cascades is prerequisite to
cancer immunotherapies
F Hanawa, T Okamoto, N Shibagaki and S Shimada Dept of Dermatology, University of
Yamanashi, Faculty of Medicine, Yamanashi, Japan
In established melanoma-bearing hosts, any acquired immune responses were severely restricted
in part through phosphorylated-STAT3 (pSTAT3). We had generated recombinant R9-GRIM19 fusion
protein (rR9-GRIM19) to inhibit the STAT3-mediated signaling cascades in cancer microenviron-
ment, and investigated the mechanism of antitumor effects by intratumoral (i.t.) injections of rR9-
GRIM19 in B16-bearing mice. In culture, we confirmed that IL-6 and IL-10 were the main soluble
STAT3 activators secreted from B16 cells, and that IL-6 and IL-10 were significantly reduced by pre-
treatment with rR9-GRIM19. In vivo, pSTAT3 expression in all CD4+ and CD8+ T cells of tumor-
draining LNs (DLNs) were elevated on day 5 after subcutaneous implantation of B16 cells, with dif-
ferentiation into IL-6/ IL-21/ IL-10-producing CD4+/ CD8+ T cell phenotypes. I.t. injections of
rR9-GRIM19 alone elicited marginal anti-B16 effects with partial pSTAT3 suppression in T cells of
DLNs by promoting the T cell differentiation into IL-17-producing (but not IFN-gamma-producing)
phenotypes. However, conventional active immunotherapies using with CpG-ODN and immuno-
genic antigens (e.g.; Trp2-peptide or rR9-OVA) did not have such inhibitory effects upon pSTAT3 in
either T cells. Instead, complete B16 regressions with melanoma-specific CTL expansion and dif-
ferentiation into IFN-gamma-producing phenotypes, as well as induction of memory effects, was
elicited only when combined with i.t. injections of rR9-GRIM19 plus Th1/ Tc1-inducible adjuvants
(CpG and rR9-OVA) (COG therapy) without melanoma-specific immunotherapies. We also con-
firmed that pSTAT3 expressions in all CD4+ and CD8+ T cells of DLNs from COG-treated B16-
regression mice were completely reverted to the basal level. All these data indicated that rR9-GRIM19
is a novel and indispensable adjuvant for the strong antitumor effects in cancer-bearing hosts.
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The expressions of T cell immunoglobulin and mucin domain molecules on peripheral blood
mononuclear cells and skin lesions of sarcoidosis patients
K Mizuno, W Inoue, C Miyake, M Osawa, H Tanimura, F Yamazaki and H Okamoto
Dermatology, Kansai Medical University, Moriguchi, Japan
Sarcoidosis is a T helper (Th) 1-mediated inflammatory disease with unknown aetiology, charac-
terized by the formation of noncaseating granulomas, and involving accumulations of mono-
cyte/macrophage-lineage cells and T cells. T cell immunoglobulin and mucin domain (Tim) proteins
regulate activation and function of CD4+ T cells and are differentially expressed on Th1 and Th2
cells. In humans, Tim-1 protein is associated with Th2 cell responses and Tim-3 preferentially is
expressed on fully differentiated Th1 cells but not on Th2 cells. Furthermore, Tim-3 is a regulator for
key pro-and anti-inflammatory cytokine production in human monocytes. In this study, we investi-
gated whether Tim molecules could play a role in the pathogenesis of sarcoidosis. Tim-1+ T cells
and Tim-3+ T cells in peripheral blood were significantly increased in sarcoidosis patients com-
pared with healthy controls. The relative frequency of both T cells was correlated with the serum
ACE and soluble IL-2 receptor levels. On the other hands, the relative frequency of Tim-3+ mono-
cytes was decreased in the patients compared with controls, while Tim3- monocytes was signifi-
cantly increased in the patients and expressed intracellular IL-12. Tim-1+ cells and Tim-3+ cells
were present in and around the granulomas of sarcoidal skin lesions, respectively. These findings
indicate the critical role of Tim molecules in the regulation of Th1/Th2 polarization in sarcoidosis.
032
CXCR3 deficiency prolongs Th1-type contact hypersensitivity
M Sugaya,1 H Suga,1 T Miyagaki,1 H Ohmatsu,1 H Okochi2 and S Sato1 1 Department of
Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan and 2 Department of
Regenerative Medicine, Research Institute, National Center for Global Health and Medicine,
Tokyo, Japan
Sensitization and challenge using dinitrofluorobenzene (DNFB) induce contact hypersensitivity
(CHS) with Th1 cell infiltration, whereas those using FITC generate CHS with Th2 cell infiltration.
In this study, we attempted to determine the role of CXCR3, a chemokine receptor, in Th1- and Th2-
type CHS induced by DNFB or FITC using CXCR3-deficient (CXCR3-/-) mice. Ear swelling was pro-
longed after DNFB challenge in CXCR3-/- mice, which was accompanied by increased Th1 cytokines
and decreased TGF-β and IL-10 expression at a late time point of CHS, while there was no signifi-
cant difference between wild-type and CXCR3-/- mice in FITC-induced CHS. In Th1-type CHS, the
number of regulatory T cells (Tregs) was decreased in the challenged ear of CXCR3-/- mice com-
pared to that of wild-type mice, suggesting that CXCR3 would be important in migration of Tregs
into the site of inflammation. Moreover, we examined the characteristics of CXCR3+ Tregs both in
vitro and in vivo, revealing that CXCR3+ Tregs expressed high levels of TGF-β and IL-10 as well as
IFN-γ compared to CXCR3- Tregs. DNFB-specific CD8+ T cells as well as Tregs expressed CCR4,
which may mediate their migration to the skin in the absence of CXCR3. BrdU proliferation assay
suggested that CXCR3+ Tregs function as potent immunoregulatory cells to suppress Th1-type immune
responses. When CXCR3-/- mice were injected with CXCR3+ Tregs, the prolonged ear swelling
induced by DNFB was normalized. Taken together, our results suggest that CXCR3+ Tregs play a
key role for quenching Th1-type CHS.
033
Opposing immune reactions drive psoriasis and eczema
M Quaranta,1 S Eyerich,1 A Cavani,2 CB Schmidt-Weber,1 J Ring3 and K Eyerich3 1 Center of
Allergy and Environment (ZAUM), Technische Universität and Helmholtz Center Munich,
Munich, Germany, 2 Laboratory of experimental immunology, IDI-IRCCS, Rome, Italy and 3
Department of Dermatology and Allergy, Technische Universität Munich, Munich, Germany
Although innovative therapeutic approaches become available for both psoriasis and to a lesser
extent for eczema, causative treatments do not exist. Here, we used our previously published model
of patients with co-existing psoriasis and inducible eczema reactions towards house dust mite or
nickel (n = 16) to investigate the pathogenesis of psoriasis and eczema simultaneously in the same
patient. Biopsies of acute eczema reactions and active neighboring psoriasis plaques were clini-
cally and histologically investigated. T cells isolated from lesional skin were phenotyped for cytokine
secretion by ELISA and flow cytometry. To understand signaling networks underlying these two
conditions, whole transcriptome analysis was performed. Clinically, all analyzed psoriasis patients
developed typical eczema upon antigen challenge. Histological analysis revealed typical hall-
marks for eczema and psoriasis, whereas the array analysis highlighted a clear cutting-edge picture
of the pathogenesis of these two conditions. Bioinformatic analysis of the array results led to the
identification of novel pathways, either unique or shared between psoriasis and contact eczema
that might be translated into new therapeutics. Furthermore, a number of possible disease biomarkers
were identified, thus paving the way to personalized medical treatment. In conclusion, we show
that psoriasis and eczema are trigged by specific immune reactions rather than genetic factors.
034
Anti-inflammatory effect of cholecystokinin in skin disorders
K Tatsuno, J Sakabe, K Nishida, H Yamaguchi, S Hirakawa and Y Tokura Dermatology,
Hamamatsu University School of Medicine, Hamamatsu, Japan
Cholecystokinin (CCK) is a major gastrointestinal peptide hormone, which induces the release of
bile and other digestive enzymes to facilitate digestion of fat and protein. It is also known to pos-
sess immunomodulatory actions, and predominant anti-inflammatory effect has been suggested in
pancreatitis and arthritis models. We have previously shown that topical application of CCK8S exerts
an anti-pruritic effect in mice, demonstrating the potential for dermatological therapeutic usage.
Nevertheless, studies relating to the interaction of this unique peptide with skin are still very lim-
ited. We sought to investigate the function of CCK on skin, by primarily focusing on inflammatory
skin disorders. To evaluate the role of CCK in atopic dermatitis (AD), serum CCK8 level of AD patients
was evaluated by ELISA. Various factors influence serum CCK concentration, and food intake is
known to raise the value by approximately 10-folds. Therefore, we selected patients with serum
CCK8 concentration below 100 pg/mL, and in this specific group of patients, a negative correlation
was seen between serum CCK8 level and serum IgE concentration (R2=0.80). In contact hypersen-
sitivity model using mice, topical application of CCK8S before sensitization and/or elicitation sig-
nificantly attenuated the ear swelling in CCK8S applied groups compared to CCK untreated mice
(P<0.005). Additionally, in the in vitro assay, cultured human vascular endothelial cells were pre-
pared, and upon stimulation with TNF-α, marked expression of intercellular adhesion molecule-1
(ICAM-1) was observed using confocal microscopy. This augmented expression was profoundly
depressed by the addition of CCK8S, particularly on the cell surface. Furthermore, RT-PCR analy-
sis confirmed that the expression of mRNA for ICAM-1 was also decreased by the addition of CCK8S.
The present study indicates that this novel peptide is capable of exerting strong anti-inflammatory
function in the skin, and the association with inflammatory skin disorders such as AD is addressed.
035
TACE/ADAM17 deficiency in epidermis leads to IL-17A-associated inflammation with atopic
dermatitis-like phenotype
T Kobayashi,1 K Horiuchi,2 T Adachi,1 H Kawasaki,1 M Amagai1 and K Nagao1 1 Dermatology,
Keio University School of Medicine, Tokyo, Japan and 2 Orthopedic Surgery, Keio University
School of Medicine, Tokyo, Japan
TACE (tumor necrosis factor-α converting enzyme), or ADAM17 (a disintegrin and metalloproteinase)
is a membrane-bound proteolytic enzyme that regulates cell proliferation and differentiation. We
recently developed Taceflox/flox/Sox9-Cre mice, in which TACE/ADAM17 is absent in epidermis (TACE
cKO), to study them in the context of hair follicle biology. Unexpectedly, TACE cKO manifested phe-
notypes that closely resembled atopic dermatitis (AD). They exhibited intense scratch behavior and
chronic skin inflammation with mast cell and T cell infiltration. Skin barriers were disrupted as deter-
mined by Raman spectrometer, and serum IgE was increased. Major proteins in the epidermal dif-
ferentiation complex including filaggrin were not remarkably changed, however. We identified via
gene array that Il-17a expression was dramatically increased, and FACS analysis revealed promi-
nent infiltration of Th17 cells as well as IL-17A producing-γδ T cells in epidermis, and increased
numbers of Th1, Th2, and Th17 cells in skin-draining lymph nodes. IL-17A-producing cells in epi-
dermis also expressed IL-22. Consistently, increased mRNA expression of the Th17-driven cytokines
IL-1β and IL-23a were detected in TACE cKO epidermis. Crossing TACE cKO to Rag2 KO or c-Kit
KO mice demonstrated that lymphocytes modestly, but significantly contributed to AD-like pheno-
type, whereas mast cells did not. Transplantation of WT bone marrow into TACE cKO mice failed
to rescue phenotype, indicating that TACE-deficient epidermis, rather than hematopoietic cells,
was responsible for the phenotype in TACE cKO mice. In conclusion, TACE-deficiency in epidermis
led to AD-like chronic skin inflammation associated with IL-17A. TACE cKO mice provide a novel
model to explore the mechanisms of aberrant inflammation accompanied by dysfunction of skin
barrier, an aspect shared by human AD.
036
Inhibition of STAT6 signals exacerbates IgE-mediated, basophil-dependent prurigo-like reac-
tions
T Hashimoto,1,2 T Satoh1,2 and H Yokozeki2 1 Department of Dermatology, National Defense
Medical College, Saitama, Japan and 2 Department of Dermatology, Graduate School, Tokyo
Medical and Dental University, Tokyo, Japan
Prurigo is a common skin disease characterized by urticarial papules and/or nodules with severe
itching. This condition occurs in association with various underlying diseases, such as chronic
renal failure and internal malignancies. Atopic dermatitis is also occasionally complicated by prurigo
lesions. The pathological mechanisms causing prurigo remain unclear, although Th2-type immu-
nity has been implicated in its etiology and our recent study showed a number of basophils in prurigo
lesions. The present study demonstrated that repeated intra-dermal injection of TNP-OVA to dorsal
skin of IgE-transgenic mice resulted in the development of persistent, basophil-dependent, nodular
skin lesions. Histopathologically, marked hyperkeratosis with irregular acanthosis was accompa-
nied by dense cellular infiltrate comprising mononuclear cells, eosinophils, basophils, and increased
numbers of mast cells. Marked sprouting of PGP9.5(+) nerve fibers in the epidermis was also observed.
These lesions seemed to share morphological similarities with prurigo reactions in humans. Local
cytokine profiles were characterized by elevated levels of interleukin (IL)-4, IL-13, IL-17, IL-22, IL-
31, and nerve growth factor. In vivo depletion of basophils resulted in alleviation of skin reactions,
indicating the basophil-dependent nature of this inflammation. Nuclear translocation of pSTAT6
and pSTAT3 was observed in epidermal keratinocytes. C57BL/6 mice also developed prurigo-like
lesions when repeatedly challenged with TNP-OVA in conjunction with TNP-IgE. Unexpectedly,
STAT6 (-/-) mice showed significant exacerbation of skin reactions compared with wild-type C57BL/6
mice. Consistent with this finding, local administration of STAT6 small interfering RNA resulted in
exacerbated skin inflammation. Th2 immunity mediated by STAT6 thus appears to play protective
roles in basophil-dependent prurigo-like reactions and therapies targeting Th2-type cytokines may
risk aggravating inflammation from prurigo.
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Regulation of Claudin-1 expression in Langerhans cells by EpCAM
T Ouchi and MC Udey Dermatology Branch, National Cancer Institute, NIH, Bethesda, MD
Langerhans cells (LC) express high levels of epithelial cell adhesion molecule (EpCAM; CD326), a
cell-surface protein that has been implicated in homotypic cell–cell adhesion in epithelia and in
metastasis in many carcinomas. LC also express claudin-1, a critical component of tight junctions
(TJ). LCs take up antigen on skin surfaces by extending their dendrites between keratinocytes (KC)
while forming claudin-containing TJ that maintain an effective barrier, and selectively promote
IgG1–predominant (Th2) humoral responses. To determine if EpCAM might modulate TJ that form
between LC and KC, conditional knockout mice with EpCAM-deficient LC (LC/EpCAM cKO mice)
were examined. We found that claudin-1 protein was downregulated several fold (p < 0.01) in
EpCAM-deficient LC in epidermis to almost background levels. EpCAM-deficient MHCIIhigh CD11c+
Langerin+ CD103- cells in skin-draining lymph nodes that represent epidermal LC that have migrated
from epidermis also expressed reduced levels of claudin-1. We hypothesized that EpCAM-deficient
LC would be unable to penetrate KC TJ and promote humoral responses to percutaneously applied
protein antigen. Unexpectedly, activated EpCAM-deficient LC extended their dendrites through KC
TJ, and TJ that formed between LC and KC contained ZO-1 and claudin-1 in amounts that were
indistinguishable from those involving WT LC. Flow cytometry confirmed that claudin-1 signals in
EpCAM-deficient LC under inflammatory conditions were higher than in steady state (p < 0.05),
which is consistent with the accumulation of claudin-1 at TJ in docking dendrites. Numbers of TJ-
docked dendrites that were formed by EpCAM-deficient LC after tape stripping did not differ from
those formed by WT LC. OVA patch immunization also induced robust anti-OVA IgG1 responses
in LC/EpCAM cKO mice that were comparable to those in control animals. These results indicate
that activated EpCAM-deficient LC form functional TJ with surrounding KC and do not provide strong
support for the concept that EpCAM plays a prominent role in functionally important acquisition of
external antigen by LC.
039
Epidermotropic resident memory T cells require hair follicle-derived cytokines to reside in
epidermis
T Adachi, T Kobayashi, M Amagai and K Nagao Dermatology, Keio University School of
Medicine, Tokyo, Japan
Strong antigenic stimuli in skin leads to the generation of effector memory T cells (TEM) that distrib-
ute not only to primary sites of inflammation, but also to the whole body surface as resident mem-
ory T cells (TRM), and confer long term protection. Widespread distribution of TRM represents steady-
state TEM trafficking, which mechanisms are yet to be clarified. Herein, we characterized TRM in WT
epidermis and evaluated cytokine requirement for their persistence in skin. Both CD8+ and CD4+
T cells of TRM phenotype (CD44
+ CD69+ CD103+ CD62L- CCR7-) were found in WT epidermis.
Whereas CD8+ TRM distributed both in hair follicles (HF) and interfollicular epidermis, CD4
+ TRM
existed exclusively in HF. To simulate steady-state TRM trafficking, we adoptively transferred T cells
into Rag2-/- mice. T cells accumulated to HF from day 7, and distributed in epidermis or dermis as
TRM in the absence of any inflammation, around two weeks after transfer. Given the association of
TRM with HF, we analyzed via real-time PCR for factors that might affect TEM generation. Langerhans
cells (LC) expressed IL-15, and keratinocytes in the HF isthmus expressed both IL-7 and IL-15. Lack
of LC did not affect TRM distribution. To address the contribution of keratinocyte-derived cytokines,
IL-7 KO and IL-15 KO mice were reconstituted with Rag2-/- bone marrow to obtain the setting where
IL-7 and IL-15 deficiencies were limited to peripheral tissues. Splenic T cells were then adoptively
transferred and skin was analyzed for TRM. Numbers of epidermotropic CD4
+, but not CD8+ TRM,
significantly decreased in IL-7-deficient epidermis. In contrast, epidermotropic CD8+ TRM were
decreased in IL-15-deficient epidermis, whereas CD4+ TRM were increased. Collectively, epidermal
distribution of CD4+ and CD8+ TRM required HF-derived IL-7 and IL-15, respectively, demonstrat-
ing the importance of HF-T cell crosstalk in epidermal TRM homeostasis.
041
Newly identification of a migratory subset of dermal γδ T cells that initiate contact hyper-
sensitivity by producing TNF-alpha in the draining lymph nodes
S Nakamizo,1 G Egawa,1 M Tomura,2 Y Miyachi1 and K Kabashima1 1 Dermatology, Kyoto
University, Kyoto, Japan and 2 Center for Innovation in Immunoregulative and Therapeutics,
Kyoto University, Kyoto, Japan
In the murine skin, there exist two subsets of γδT cells; dendritic epidermal T cells (DETCs) and der-
mal γδT cells. However, the role of skin γδT cells in cutaneous acquired immune responses remains
unclarified. In the present study, we generated mice lacking only dermal γδ T cells using bone mar-
row transplantation chimera and demonstrated that contact hypersensitivity (CHS) response to DNFB
was significantly reduced by dermal γδ T cell-depletion. In vitro restimulation of sensitized lym-
phocytes revealed that dermal γδ T cells promote the sensitization phase of CHS. In addition, by
means of photo-labeling system using photoconvertible protein-Kaede-transgenic mice, we demon-
strated that a fraction of γδ T cells migrated from the skin to draining lymph nodes (DLNs) promi-
nently during the sensitization phase. Majority of skin-derived γδ T cells in DLN expressed CCR6
and Vγ4 chain, suggesting that they were dermal origin. In contrast to other skin immune cells, the
migration of γδT cells to the DLNs was independent of Gαi-coupled receptors, since pertussis toxin
treatment did not prevent their migration. Moreover, coculture of dendritic cells with Vγ4-positive
γδ T cells led to a significant upmodulation of MHC class II molecules and IL-12 production in a
TNF-α dependent manner, which suggests that migrating γδ T cells activate the dendritic cell func-
tions in the DLNs. Taken together, we newly identified Vγ4-positive dermal γδT cells, which migrate
to the DLNs and establish the sensitization phase of CHS via enhancing dendritic cell functions.
040
Antigen-presenting dendritic cells maintain immunological tolerance in the oral cavity by
inducing Foxp3+ regulatory T cells
S Yamazaki and A Morita Department of Geriatric and Environmental Dermatology, Nagoya
City University Graduate School of Medical Sciences, Nagoya, Japan
Oral cavity is often affected by immunological skin disorders such as Stevens-Johnson syndrome
and Behçet diseases. However, it is unclear how tolerance versus immunity is regulated in the oral
cavity. We have previously shown that dendritic cells (DCs) excel in expanding and inducing anti-
gen-specific Foxp3+ CD25+ CD4+ regulatory T cells (T-regs). Here, we show that antigen-present-
ing DCs play a key role in inducing Foxp3+ T-regs to maintain tolerance in the oral cavity. We found
that CD11c+ DCs from oral-cavity-draining cervical lymph nodes have the capacity to induce Foxp3+
T-regs in the presence of antigen in vitro. Moreover, oral-cavity-draining cervical lymph nodes con-
tained higher frequencies of Foxp3+ T-regs and ROR-γt+ CD4+ T cells than other lymph nodes. The
high frequency of Foxp3+ T-regs in the oral-cavity-draining cervical lymph nodes was not depend-
ent on the Toll like receptor (TLR) adaptor molecules, Myd88 and TICAM-1 (TRIF). In contrast, the
high frequency of ROR-γt+ CD4+ T cells was dependent on Myd88 and TICAM-1. These data sug-
gest that, antigen-presenting DCs may play a vital role in maintaining tolerance by inducing Foxp3+
T-regs in the oral cavity where many commensals and food antigens exist.
038
Mechanistic correlations between two itch biomarkers, cytokine interleukin-31 and neu-
ropeptide β-endorphin, via STAT3/calcium axis in atopic dermatitis
C Hong,1,2,3 C Lee,3 W Yu,3 H Chuang,4 G Chen3 and H Yu3 1 Dermatology, National Yang-Ming
Univeristy, Taipei, Taiwan, 2 Dermatology, Kaohsiung Veterans General Hospital, Kaohsiung,
Taiwan, 3 Dermatology, Kaohsiung Medical University, Kaohsiung, Taiwan and 4 Public
Health, Kaohsiung Medical University, Kaohsiung, Taiwan
Itch is the cardinal symptom of atopic dermatitis (AD). β-Endorphin, a neuropeptide, is increased
in both AD skin and sera. Interleukin (IL)-31, an itch-relevant cytokine, activates IL-31 receptors in
keratinocytes. However, how IL-31 and β-endorphin interact in AD skin remains elusive. This study
aims to investigate the mechanistic interaction of IL-31 and β-endorphin in AD. This was a prospec-
tive cross-sectional study. We recruited adult patients with AD and controls according to Hanifin’s
AD criteria. Serum levels of IL-31 and β-endorphin were measured by enzyme-linked immunosor-
bent assay. Expressions of IL-31 receptor A (IL-31RA) and β-endorphin in the skin were assessed by
immunohistochemistry. Their expression in the skin and blood was compared and correlated in
patients with AD and in controls. We also treated primary keratinocytes with IL-31 and measured
calcium influx, β-endorphin production and signalling pathways to define their mechanistic inter-
actions. Our result showed β-Endorphin was increased in the supernatant from IL-31-treated ker-
atinocytes. IL-31 receptor activation resulted in calcium influx and STAT3 activation; pretreatment
with STAT3 inhibitor stopped the increase of β-endorphin. Notably, either replacement of extra-
cellular calcium or treatment with 2-aminoethoxydiphenyl borate, an inhibitor for the store-oper-
ated channel, blocked STAT3 activation. We found higher levels of blood β-endorphin and IL-31,
which were significantly correlated, in patients with AD. Moreover, IL-31RA and β-endorphin were
increased and colocalized both in AD human skin and TPA-painted mouse skin. We concluded
that IL-31 receptor activation in keratinocytes induces calcium influx and STAT3-dependent pro-
duction of β-endorphin. These results might contribute to an understanding of the regulatory mech-
anisms underlying peripheral itch.
042
Single cell tracking reveals the segregation of slow cycling memory CD8 T cells from the effec-
tor pool at the peak of the immune response
I Kinjyo,1 J Qin,1 P Mrass,1 CJ Wellard,2 M Tomura,3 O Kanagawa,3 A Miyawaki,4 PD Hodgkin2 and
W Weninger1 1 Centenary Institute, Sydney, NSW, Australia, 2 Walter and Eliza Hall Institute
of Medical Research, Melbourne, VIC, Australia, 3 Research Center for Allergy and
Immunology, RIKEN, Yokohama, Japan and 4 Brain Science Institute, RIKEN, Kobe, Japan
Upon encounter of cognate antigen, naïve T cells undergo sequential multiple cell divisions asso-
ciated with the acquisition of effector function. Following the eradication of antigen, the effector T
cell population contracts and leaves behind memory T cell population. The kinetics and mecha-
nisms that result in the generation of CD8 memory T cells have remained controversial. Here we
made use of a novel approach to dissect the proliferative behavior of effector and memory T cells,
that is single cell tracking of cell cycle progression of OVA-specific T cells transgenically express-
ing the fluorescent ubiquitination-based cell-cycle indicator (FUCCI). While G0/1 phase T cells are
indicated by red fluorescence, early S and S/G2/M T cells turn to yellow and green. Following
infection with OVA expressing influenza virus in vivo, FUCCI/OTI T cells proceeded divisions, with
decreasing red+ cells from 99% to 5% and increasing green+ cells up to 44.6% during early infec-
tion. Surprisingly, red FUCCI/OTI cells with a memory phenotype reappeared at the peak of infec-
tion. These cells had a history of vigorous prior proliferation indicated by cell trace dye dilution,
suggesting they developed from the fast dividing effector T cell pool. Next, we tracked divisions of
single cells trapped in microwells. Mathematical modeling revealed inheritance of division times
in progeny consistent with the development of distinct T cell lineages. Strikingly, in later divisions
(generation ≥8), a slow cycling subpopulation appeared with smaller cell size and expression of
memory markers. Collectively, we report a novel developmental process whereby at the height of
the immune response T cells segregate into populations within distinct proliferative histories char-
acteristic of terminal effector and memory T cells.
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A system for differentiating human monocytes into antigen presenting cells
D Khalil, S Saluja, J Futterleib, H Feng, E Robinson, D Hanlon, R Tigelaar and R Edelson
Dermatology, Yale University, New Haven, CT
In the context of physiological inflammation, human monocytes differentiate into a continuum of
antigen presenting cells spanning from macrophages (MΦ) to dendritic cells (DC). However, in most
experiments MΦ and DCs are produced and studied separately. This is despite multiple recent stud-
ies demonstrating that not only DCs but MΦ as well can migrate to lymph nodes and cross-present
antigens to T cells. We therefore sought to develop a single method to differentiate monocytes into
a range of antigen presenting cells (APCs). Experiments evaluated morphology using light microscopy,
phenotype using ten parameter flow cytometry, and function using APCs co-cultured with autolo-
gous naïve CD8+ T cells (HLA-A201+ donors) ± a “long” MART-1 (16-43) melanoma peptide (MART-
1 LP) requiring intracellular processing for effective cross-presentation of the HLA-A201/MART-1
(27-35) complex to CD8+ cells. After engaging activated platelets and serum proteins under flow
followed by 18 hr culture in RPMI 1640/15% AB serum, we discovered that fresh human mono-
cytes differentiated into mature DCs (3.96±0.61% of CD11c+ cells were CD14-
HLADR++CD83+CD86++CD80+), immature DCs (30.27±4.41% of CD11c+ were CD14-
HLADR+CD83-CD86+CD80-), and inflammatory MΦ (65.78±3.87% of CD11c+ cells were
CD14+HLADR+CD86+CD83-CD80-). Morphologically, cells had properties of MΦ (large cells with
pseudopodia extending to particles) and DCs (granular cells with limited branched projections).
Functionally, these cells together in co-culture cross-presented the MART-1 LP to autologous naïve
CD8+ T cells, as assessed by CD8+ cells co-stained with HLA-A2/MART-1 (27-35) vs control HLA-
A2/gp100 dextramers following stimulation with MART-1 LP (vs no peptide). To the best of our knowl-
edge, this is the first study to report a single method to concurrently produce cells across the inflam-
matory APC spectrum. Ultimately, since this system requires only a brief ex vivo intervention, cells
can be returned to the patient quickly in possible future antigen presenting cell based immunother-
apy.
044
New role of IL-17A as an inducer for Th2 in murine atopic dermatitis
S Nakajima, Y Miyachi and K Kabashima Dermatology, Kyoto University Graduate School of
Medicine, Kyoto, Japan
Atopic dermatitis (AD) is generally regarded as a T helper 2 (Th2)-mediated inflammatory skin dis-
ease. However, the number of IL-17 positive cells is increased in the peripheral blood and the
acute skin lesion of AD patients. Therefore, it is important to evaluate the role of IL-17A in the
development of AD. To this end, we used IL-17A deficient (IL-17-/-) mice in a hapten-induced AD-
like mouse model. We found that IL-17A induced TSLP and TARC/CCL17 mRNA expressions in the
lesional skin and promoted Th2 differentiation in the draining lymph nodes. Consistently, the serum
IgE level in IL-17-/- mice was significantly lower than that in wild-type mice after repeated hapten
application. We also found that the main producer of IL-17A in the lesional skin was dermal γ4+
CCR6+ γδT cells, which migrated to the epidermis. To further give in-depth consideration to the
above findings, we used flaky tail (Flgft) mice that exhibit AD-like skin lesions with elevated IgE.
We crossed Flgft mice with IL-17A-/- mice and generated Flgft mice deficient in IL-17A (IL-17A-/-
Flgft mice). IL-17A-/- Flgft mice showed impaired serum IgE level compare to Flgft mice in the steady
state. In addition, the number of IL-4 producing cells in the skin draining lymph nodes was signif-
icantly decreased in IL-17A-/- Flgft mice compare to that in Flgft mice. Moreover, epidermal thick-
ness tended to be decreased in IL-17A-/- Flgft mice compared to Flgft mice. In line with the result
of the hapten-induced AD model, the main producer of IL-17A in the skin of Flgft mice was γ4+
γδT cells. Taken together, our results suggest that dermal γ4+ γδ T cells migrating into the epidermis
are the essential sources of IL-17A in the AD-like skin lesions, and that IL-17A promotes Th2 induc-
tion and antigen-specific IgE production in line with TSLP and CCL17 induction in keratinocytes.
Therefore, IL-17A seems to play an important role in the development of AD.
045
Langerhans cell derived IL-6 is required for the differentiation of Th17 during skin infection
with Candida albicans
BZ Igyarto,1 ES Jarrett,1 A Bobr,1 M Gerami-Nejad,2 J Berman2 and DH Kaplan1 1 Department of
Dermatology, Center for Immunology, University of Minnesota, Minneapolis, Minneapolis,
MN and 2 Department of Molecular and Cellular Biology, University of Minnesota,
Minneapolis, Minneapolis, MN
Langerhans cells (LC), CD11b+ dermal dendritic cells (dDCs) and CD103+ dDC acquire antigen in
the skin and promote the initiation of adaptive immune responses in regional lymph nodes. We
recently demonstrated using a Candida albicans skin infection model that these DC subsets all
acquire antigen but LC are necessary and sufficient for the differentiation of naïve T cells into the
Th17 phenotype while CD103+ dDC were required for the development of Th1. In other systems,
Th17 differentiation requires the presence of TGFβ and either IL-6 or IL-1β depending on the tissue
as well as IL-23 for the maintenance of the Th17 phenotype. Activated LC and dDC produce high
levels of these cytokines. Langerin-Cre MyD88fl mice in which LC cannot response to most TLR
agonists have reduced expression of many of these cytokines and fail to produce a robust Th17
response. To test the importance of individual LC-derived cytokines, we generated a series of mice
in which LC were rendered unable to secrete a particular cytokine. WTÇIL-1β-/- bone-marrow
chimeras in which LC and non-hematopoetic cells cannot produce IL-1β, the development of Th17
in response to C. albicans skin infection was unaffected. Similarly, Th17 development was intact in
WTÇIL-12p40-/- chimeras indicating that LC-derived IL23 is not required. In contract, develop-
ment of Th17 was significantly reduced in WTÇIL-6-/- chimeras. Since TGFβ-/- and Langerin-Cre
TGFβfl mice lack LC, we used Langerin-CreERT2 TGFβfl mice to test the requirement for LC-derived
TGFβ. Tamoxifen treatment efficiently ablated TGFβ expression in LC but did not affect the devel-
opment of Th17. Thus, although Th17-inducing cytokines are secreted by LC and dermal DC after
infection with C. albicans, only LC-derived IL-6 appears to be non-redundantly required.
046
Langerhans cell and CD103+ dermal dendritic cell promote Tfh in the steady-state
ES Jarrett,1 SM Zurawski,2 G Zurawski,2 DH Kaplan1 and BZ Igyártó1 1 University of Minnesota,
Minneapolis, MN and 2 Baylor Institute, Dallas, TX
Directing antigen to dendritic cells via antibody/antigen conjugates that target antigen-uptake recep-
tors is a highly efficient vaccination technique and also allows for in vivo examination of the effect
of antigen presentation by particular DC subsets. Classic experiments determined that antigen pres-
entation in the absence of DC activation led to deletional tolerance. Antibodies directed to the C-
type lectin Langerin which is expressed by Langerhans cells (LC) and CD103+ dermal DC (dDC)
have been shown in short-term studies to induce strong CD4 and CD8 T cell responses. To study
the effects of antigen presentation isolated to LC or CD103+ dDC in the steady-state, we performed
a series of experiments in which either 1) transgenic mice that express human Langerin only in LC
were immunized with anti-human Langerin/antigen complexes or 2) mice lacking LC were immu-
nized with anti-mouse Langerin/antigen complexes. In both cases the DC remained unactivated and
antigen was exclusively found on either LC or CD103+ dDC, respectively. Both DC subsets, were
able to promote proliferation of MHC-II tetramer binding endogenous CD4 T cells that peaked at
day 7 and slowly declined over time without evidence of deletion. LC but not CD103+ dDC induced
a small expansion of antigen-specific Foxp3+ Treg. In contrast, both subsets induced strong expan-
sion of a population of antigen-specific CXCR5+, PD-1+ CD4 T cells that expressed IFNγ, IL-21 and
IL-4 which is most consistent with follicular helper T cells (Tfh). In addition, immunization led to
the formation of germinal centers in regional LN and was accompanied with a robust humoral
response. Thus, presentation in the steady-state by LC and CD103+ dDC promotes Tfh and humoral
responses but not deletional tolerance.
047
RNase7 regulates TH2 cytokine production by activated human T-cells
V Kopfnagel,1 J Hader2 and M Kleine3 1 Department of Dermatology and Allergy, Hannover
Medical School, Hannover, Germany, 2 Department of Dermatology, University Hospital
Schleswig-Holstein, Kiel, Germany and 3 PLANTON GmbH, Kiel, Germany
One of the major antimicrobial peptides (AMPs) secreted by keratinocytes is RNase7, a member of
the RNaseA family. RNase7 is constitutively expressed in the epidermis of healthy human skin and
has been found to be upregulated in chronic inflammatory skin diseases such as atopic dermatitis
and psoriasis. In addition to their antimicrobial activity immunregulatory functions have been pub-
lished for several AMPs. In lesional skin of patients with atopic dermatitis and psoriasis activated T-
cells might be directly exposed to RNAse7. Here we investigated the influence of RNase7 on acti-
vated T-cells. In the current study we demonstrate that treatment of activated human CD4+ T-cells
and TH2 cells with RNase7 significantly reduced the production of the TH2 cytokines IL-4 and IL-
13 by activated human T-cells while IFNγ and IL-2 were not regulated. This effect was was not due
to enhanced apoptosis. To analyze if ribonuclease activity is required for the regulation of the TH2
cytokine release we repeated our experiments with a ribonuclease-inactive recombinant RNase7
mutant. Interestingly, our data show that RNase7 ribonuclease activity is dispensable for the observed
regulatory effect. Furthermore, we were able to show that the inhibition of TH2 cytokine produc-
tion by RNase7 is mediated by a down-regulation of GATA3 activity. Our data indicate that RNase7
has immunmodulatory functions on TH2-cells and might foster a TH1 cytokine environment in the
skin.
048
A study on the heterogeneity of CD16+ myeloid cells in human blood that serve as precur-
sors of inflammatory dermal dendritic cells
P Eckstein,1 T Döbel,1 A Kunze,1 A Enk,1 M Bachmann2 and K Schäkel1 1 Department of
Dermatology, Ruprecht-Karls-Universität, Heidelberg, Germany and 2 Institute of
Immunology, Technische Universität, Dresden, Germany
Dermal dendritic cells (DCs) are important regulators of skin immune responses. Among these we
previously identified slan (6-sulfo LacNAc) DCs as a population of TNF-alpha producing dermal
inflammatory DCs (TIP-DCs) in psoriasis and lupus erythematosus. SlanDCs in blood share func-
tional and phenotypic features with a larger cell population now categorized as non-classical mono-
cytes (CD16high CD14low-negative). So far, there are no parameters or cell surface markers that
allow studying the heterogeneity of these cells. To this end we started a program to generate mon-
oclonal antibodies with specificity for CD16+ myeloid cells. We thereby obtained the monoclonal
antibody DD3 that turned out to be highly specific for a not yet characterized subset of human
CD16high CD14low-negative cells. Our phenotypic studies combining the anti-slan mAb (M-
DC8) and the new mAb DD3 allowed us to distinguish for the first time between very distinct sub-
sets of CD16high CD14low-negative cells. We next aimed for an extensive side by side study on
the LPS-induced cytokine producing capacity of different DC and monocytes subsets. These stud-
ies clearly showed that in contrast to all other antigen presenting cells (APCs) investigated (CD1c+
DCs, CD141+ DCs, CD14 monocytes, CD14dim monocytes) slanDCs were the most prominent
source of IL-12p40/p70, followed by the new mAb DD3-defined subset of non-classical monocytes.
These studies underscore that the previously ill defined population of CD16+ myeloid cells in blood
can be further dissected into functionally distinct subpopulations. Furthermore, we think that unrav-
eling the heterogeneity of human inflammatory dermal DCs at the level of their precursor cells in
blood will ultimately allow a better understanding of immune regulation in the skin.
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Human Th9 cells: A novel skin homing T cell subset with potent autocrine and paracrine proin-
flammatory properties
C Schlapbach,1,2 C Yang,2 R Watanabe,2 A Gehad,2 E Guenova,2 J Teague,2 N Yawalkar,1
TS Kupper2 and RA Clark2 1 Department of Dermatology, University of Bern, Bern, Switzerland
and 2 Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School,
Boston, MA
IL-9 producing Th9 cells have been proposed as a novel subset of helper T cells and animal studies
suggest a role in tumor immunity and in allergic/autoimmune inflammation. Prior studies have been
limited to genetically modified mice or to Th9 cells differentiated in vitro using TGF-β; studies of
memory Th9 cells from human blood and tissues are conspicuously lacking. We isolated tissue res-
ident T cells from healthy human skin, intestine and lung and found Th9 cells only in skin. IL-9 was
also expressed in skin lesions of psoriasis and atopic dermatitis. We next sorted blood T cells into
3 populations (skin tropic (CLA+), gut tropic (α4β7+) or neither) and studied cytokine production
and pathogen specificity. IL-9 was produced only by skin tropic T cells and many were specific for
C. albicans. IL-9 production was transient after activation, was not dependent on TGF-β, and Th9
cells did not express other T lineage cytokines (IFN-γ, IL-17, IL-13) but did co-express TNFα/granzyme
B, establishing their identity as a distinct T cell subset. IL-9 receptor was highly expressed by CLA+
T cells suggesting Th9 cells may be both a source and target of IL-9. Blocking IL-9 at the initiation
of in vitro culture strongly inhibited up-regulation of IL-9, IFN-γ, IL-13, and IL-17 in CLA+ T cells,
suggesting IL-9 production was needed for maximal inflammatory cytokine production of skin tropic
Th1, Th2, Th9 and Th17 cells. In summary, human Th9 cells are preferentially skin-tropic or skin-
resident. The C. albicans specificity of many Th9 cells suggests they may defend against extracellu-
lar pathogens. Given their ability to initiate and enhance production of other inflammatory cytokines,
Th9 cells may also participate in initiating and maintaining cutaneous inflammation.
051
HIV infection predisposes skin to toxic epidermal necrolysis via depletion of skin-directed
CD4(+) T cells
CH Yang and AP Saavedra Dermatology, Brigham and Women’s Hospital, Boston, MA
Infection with the human immunodeficiency virus (HIV) is a well-known risk factor for the devel-
opment of adverse cutaneous drug eruptions (ACDEs); however little is known about the patho-
genesis of ACDEs or the mechanism by which HIV infection predisposes individuals to a higher inci-
dence of ACDEs. Additionally, the mortality of severe ACDEs remains high, and there is need for
investigation into new treatment modalities and immunological mediators that may serve as poten-
tial targets for such new therapies. To assess whether an altered immunological state contributes to
the development of ACDEs in HIV-infected individuals, skin biopsies of toxic epidermal necrolysis
(TEN) lesions from HIV-positive and non-infected patients were examined via immunohistochem-
istry to characterize the associated inflammatory infiltrates. An 8-fold increase (p=0.006) in the
ratio of CD8(+) to CD4(+) T cells was observed in the dermis of HIV-positive patients afflicted with
TEN compared to HIV-negative controls. This increase was associated with a decrease in the absolute
number of dermal CD4(+) T cells (p=0.044); however no significant difference was observed in the
total number of CD8(+) T cells (p=0.351) between HIV infected individuals and controls. Further-
more, there was a trend towards a decreased number of CD25(+)T cells in the dermis of HIV infected
skin (p=0.062). Our findings suggest that the increased risk of ACDEs in HIV-positive individuals
may be attributed to a shift in the CD8(+) to CD4(+) ratio towards the effector CD8(+) T cell popu-
lation. The tropism of the HIV virus for CD4(+) T cells may explain the substantial decrease in CD4(+)
T cells but preservation of the CD8(+) T cell response among HIV patients with TEN. In addition,
these results identify CD4(+)CD25(+) regulatory T cells as an important mediator in the pathogen-
esis of ACDEs and as a potential target for future cell-specific TEN therapy.
053
Beta arrestin-2 signalling attenuates contact allergic inflammation and inhibits proinflam-
matory chemokine production by keratinocytes
E Gaffal,1 M Cron,1 N Glodde,1 R Schroeder,2 E Kostenis2 and T Tueting1 1 Dep. of Dermatology
and Allergy, University of Bonn, Bonn, Germany and 2 Institute for Pharmaceutical Biology,
University of Bonn, Bonn, Germany
Beta arrestins are ubiquitously expressed adapter proteins that participate in G-protein receptor sig-
nalling through receptor desensitization and internalization. They also act as multifunctional adap-
tor proteins that direct the recruitment, activation and scaffolding of various cytoplasmic signalling
complexes including MAPK and non-receptor tyrosine kinases. In beta arrestin-2 deficient mice
(Arrb2-/-) a decreased recruitment of T cells into allergic lung tissue and an increased infiltration of
neutrophils into inflamed or wounded skin was described. Given these opposing effects in differ-
ent immune cell subsets we investigated the role of beta arrestin-2 in the regulation of contact hyper-
sensitivity (CHS) responses to the obligate contact sensitizer DNFB. We found significantly increased
allergic ear swelling in beta arrestin-deficient mice compared to wildtype animals. Immunohisto-
logical analyses revealed a strikingly increased neutrophil infiltration with abundant subcorneal
pustules in inflamed ear tissue of animals lacking beta arrestin-2. mRNA levels of neutrophil-
attracting chemokines including CXCL1, CXCL-2 and CCL8 were elevated in inflamed ear tissue of
Arrb2-/- mice. Experiments with adoptive transfer of sensitized lymphocytes and bone marrow
chimeric mice demonstrated a role for beta arrestin-2 in radioresistant skin cells for the regulation
of inflammatory responses during the challenge phase of CHS. We found that beta arrestin-2 defi-
cient keratinocytes secreted higher levels of immune cell recruiting chemokines under basal and
inflammatory conditions. Taken together, the experimental results suggest that beta arrestin-2 sig-
nalling attenuates allergic inflammation by inhibiting chemokine production in epidermal ker-
atinocytes.
052
Characterisation of epidermal and dermal T cells in healthy human skin
S Cheuk, L Eidsmo and M Ståhle Department of Medicine Solna, Karolinska Institutet,
Stockholm, Sweden
Healthy human skin contains a large number of T cells. Depending on the local microenvironment,
skin derived T cells have the ability to act either as regulatory or effector T cells. Tissue resident mem-
ory T cells (Trms) are retained in murine skin after infection and are identified by CD103 and
CD49a expression. Trms provide a first line of defence against secondary infection or viral reacti-
vation. Similar T cells have been shown in human skin after HSV infection. In this study, we analysed
the different subpopulations of CD4+ and CD8+ T cells present in healthy human skin. Cell sus-
pensions prepared from epidermis, dermis and peripheral blood were analysed by flow cytometry
or RNA expression within 24 hours of sample collection. Histology was performed on cryopreserved
skin biopsies. Intracellular IFNγ and IL-17 production was analysed following PMA/Ionomycin stim-
ulation by flow cytometry. We found a dominance of CD4+ over CD8+ T cells in healthy epider-
mis and dermis. A substantial number of epidermal CD4+ and CD8+ T cells expressed CD103+
whereas CD49a was only detected in a proportion of epidermal CD8+ cells. Dermal T cells con-
tained a lower percentage of CD103 expressing T cells as compared to epidermis. The majority of
epidermal and dermal CD4+ T cells were CD45RO+ CD62L-. However, a prominent population
of CD45RO+CD62L+ CD4+ T cells was also present in dermis. Two distinct populations of CD45RA-
RO+CD62L- or CD45RA+RO-CD62L- CD8+ T cells were present in epidermis and dermis. Skin T
cells contained at least a ten-fold higher proportion of IL-17A expressing CD4+ and CD8+ T cells
as compared to their circulating counterpart. CCR6, a chemokine receptor expressed on Th17
cells, was expressed on almost all CD103+ CD45RO+ CD4+ T cells and on a majority of CD103+
CD45RO+ CD8+ T cells in both epidermis and dermis. In conclusion, we showed a heterogeneous
population of memory T cells present in healthy human epidermis and dermis. CD103+CCR6+
CD45RO+ expressing T cells may represent a subset of IL17A producing Trms residing in healthy
human skin.
050
IRF8 and IRF4 may work cooperatively in CD8 T cell effector differentiation
F Miyagawa,1,2 H Zhang,2 SI Katz2 and H Asada1 1 Dermatology, Nara Medical University,
Kashihara, Japan and 2 Dermatology, NCI/NIH, Bethesda, MD
We previously reported that interferon regulatory factor 8 (IRF8), a transcription factor that belongs
to the IRF family, integrates TCR/co-stimulation and γc-cytokine signaling pathways and drives effec-
tor differentiation of CD8 T cell. We demonstrated that these two signaling pathways synergistically
promote the generation of cytotoxic T cells and IRF8 is persistently activated by these two signals.
Blocking these signaling pathways by either ZAP70 or Jak3 inhibition in vitro abrogated IRF8 upreg-
ulation and inhibited effector differentiation of CD8 T cells. Using K14-mOVA Tg mice that develop
graft-vs-host disease (GvHD) after transfer of syngeneic CD8/OT-I T cells we showed that OT-I/IRF8KO
cells induced less severe GvHD and attenuated effector functions, including cytotoxicity and IFN-
γ production. However, genetic depletion of IRF8 did not completely abrogate the GvHD response
or effector functions in vivo, suggesting that other transcription factors may be involved. Since IRF8
exerts its function(s) by forming a dimer with other IRF family members, we assessed other IRF fam-
ily members for pairing. Only IRF4 showed an expression pattern similar to IRF8. IRF4 was upreg-
ulated upon activation of CD8 T cells and was suppressed by blocking TCR/co-stimulation or γc-
cytokine signaling pathways, suggesting that IRF4 may drive effector differentiation of CD8 T cells
together with IRF8. To determine how IRF8 and IRF4 expression relates to that of T-bet and Eomes
(two important transcription factors that also play a role in CD8 T cell effector function) expression,
we performed real-time PCR using activated CD8 T cells cultured in the presence of a ZAP70 inhibitor
or a Jak3 inhibitor. The results demonstrated that T-bet and Eomes did not show parallel expression
patterns to IRF8 and IRF4 suggesting that IRF8 and IRF4 function independently of T-bet and Eomes
and may be useful targets for modulating these types of immune responses.
054
Time course effects of topical Dermatophagoides farinae applications on the progression of
atopic dermatitis-like symptoms in NC/Nga mice
J Kim, M Jeong, K Park, M Lee and S Seo Department of Dermatology, Chung Ang University
College of Medicine, Seoul, Republic of Korea
Atopic dermatitis (AD) is not a simple inflammatory skin disease but is a quite complicated skin
syndrome influenced by genetic background and different types of environmental factors such as
allergens and microbes. Although various animal models have been suggested to analyze the patho-
genesis of AD and the development of therapeutic drugs for the disease, there are few reports to
evaluate each stage of the skin condition occurring in the course of AD. In this study, we identified
the correlation between the expressions of immunologic factors and each stage of AD progression.
To evaluate the time course effects of topical allergen stimulations on the onset and duration of AD-
like symptoms, we applied Dermatophagoides farinae extract (DfE) together with skin barrier dis-
ruption on the upper dorsal skin of NC/Nga mice twice a week for 8 weeks. Repeated application
of DfE rapidly elevated the dermatitis score followed by histologic changes of the skin at the each
stage of AD progression in a time-dependent manner. From the 2nd week of the DfE application,
the skin surface appeared the dryness and hemorrhage, and edema and excoriation occurred from
the 3rd week. Interestingly, we found that skin barrier disruption with 4% Sodium dodecyl sulfate
(SDS) twice a week failed to develop the AD-like skin lesions in NC/Nga mice. We also identified
the correlation between the expressions of AD-related immune regulatory factors, such as
immunoglobulin (Ig) subclasses and cytokines, and the each stage of AD progression. The changes
in the expressions of total and D.farinae-specific Ig E, G1, G2a in plasma as well as splenic Th1, 2,
17 cytokines affected the change at the each stage of AD-like skin symptoms. In conclusion, our
results suggest that we should pay attention to the characteristics of each stage of AD progression
and choose the suitable stage of animal model not only to elucidate the pathogenesis of AD but
also to develop and evaluate the therapeutic drugs for AD.
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Human Langerhans cells potently induce Th1 cytokines in the presence of poly(I:C), but are
less responsive than dendritic cells towards bacterial stimuli
A Said, M Schäfer-Korting and G Weindl Institute of Pharmacy (Pharmacology and Toxicology),
Freie Universität Berlin, Berlin, Germany
Dendritic cells (DC) are professional antigen presenting cells and provide a link between the innate
and adaptive immune system. Langerhans cells (LC) represent a highly specialized subset of DC
localized in the epidermis, an environment extensively exposed to pathogens. Due to their unique
location it has been suggested, that resident LC are ideally positioned to capture invading viruses
and possibly induce anti-viral immunity, but in contrast to dermal DC, contribute to tolerance towards
bacterial commensals. Therefore, we analyzed the maturation and cytokine production of human
immature monocyte-derived DC (MoDC) and LC-like cells (MoLC) upon stimulation with TLR lig-
ands, pro-inflammatory cytokines and soluble CD40 ligand (CD40L). MoLC were distinguished from
MoDC by the expression of E-Cadherin, Langerin and TROP-2. Pro-inflammatory cytokines as well
as CD40L highly induced the expression of co-stimulatory molecule CD86 and activation marker
CD83 after 24h of activation. MoDC, representing dermal DC subsets, were strongly activated by
bacterial stimuli, leading to upregulation of CD83 and CD86, together with production of IL-6, IL-
10, IL-12p70, IL-23 and IFN-γ. In contrast, MoLC showed impaired responsiveness to bacterial TLR
ligands, but highly matured in the presence of poly(I:C), a molecular pattern associated with viral
infection. The accompanied production of IFN-γ and IL-12p70 indicates the development of a Th1
response by activated MoLC. Additionally, we characterized the migratory capacity towards the
CCR7 ligand, CCL21. Activation for 48h led to increased migration in both subsets according to
their maturation status, but showed impaired migration of mature MoLC compared to MoDC, sug-
gesting a crucial contribution of dermal DC in the initiation of immunity. Taken together, these data
underline the pivotal role of the different DC subsets for the regulation of immune responses in
human skin.
056
Effect of topical application of Quercetin on atopic dermatitis in NC/Nga mice
S Choi,1 M Jeong,1 J Kim,1 K Park,1 M Lee,2 S Joo3 and S Seo1 1 Dermatology, Institute of Atopic
Dermatitis, Department of Dermatology, Chung-Ang University College of Medicine, Seoul,
Republic of Korea, 2 Laboratory Medicine, College of Medicine, Department of Laboratory
Medicine, Chung-Ang University College of Medicine, Seoul, Republic of Korea and 3 Marine
Molecular Biotechnology, Gangneung-Wonju National University, Gangneung, Republic of
Korea
Atopic Dermatitis (AD) is a chronic inflammatory skin disease that commonly begins in childhood.
Quercetin-3-O-α-L-rhamnopyranosyl-2”-gallate (QRG), which was isolated from the bark of Acer
ginnala Maxim grown natively in Korea, has been known to have several biological effects, includ-
ing anti-oxidative, anti-inflammatory and anti-cancer activities. In this study, we examined the effect
of topical application of QRG on skin inflammation and AD-like skin lesions in mouse models. Over
a period of eight weeks, mice applied daily to QRG for 4 weeks after received twice a week appli-
cation of 100 mg Dermatophagoides farinae (Df) ointment on back for 4 weeks. Topical applica-
tion of QRG were down-regulated the development of AD-like skin lesions in NC/Nga mice. Inter-
estingly, QRG markedly decreased inducible nitric oxide synthase (iNOS) and cyclooxygenase
(COX)-2 mRNA expression in skin. QRG also significantly suppressed the level of total plasma
Immunoglobulin (Ig) E induced by topical Df-stimulation. We also showed that topical application
down-regulated the expression of representative cytokines, Interleukin (IL)-4, -5 and -13, induced
by Df stimulation. In the present study, we demonstrated that topical application of QRG was able
to improve Df-induced AD-like inflammatory responses. These results demonstrate that QRG might
be beneficial in the treatment of AD.
057
Induction of regulatory T cells by human antimicrobial peptides
A Schwarz, A Bruhs and T Schwarz Department of Dermatology, University Clinics Schleswig-
Holstein, Kiel, Germany
Antimicrobial peptides (AMP) are small molecules which are released by a variety of cells includ-
ing keratinocytes. AMP were initially described according to their antimicrobial activity. They are
essential components of the innate immune response and most responsible for antibacterial defense.
Recently it was discovered that AMP exert additional activities beyond their antimicrobial capaci-
ties. They were demonstrated to influence the adaptive immune system by modulating antigen pre-
senting cells. Recently we demonstrated that the murine beta defensin-14 (mBD-14) is able to induce
regulatory T cells (Treg). mBD-14 appears to shift non-regulatory T cells into Treg by inducing the
Treg-associated transcription factor Foxp3. Here, we studied whether human AMP exert similar
immunosuppressive features. For this purpose human peripheral blood mononuclear cells obtained
from buffy coats of healthy donors were separated into CD4+CD25+ and CD4+CD25- cells by mag-
netobead separation. The non-regulatory CD4+CD25- fraction was incubated with the human
AMP hBD-2,-3, psoriasin and RNAse-7 respectively. Intracellular FACS analysis 24 hours later
revealed upregulation of Foxp3 and neuropillin upon incubation with hBD-3. CTLA-4 was moder-
ately increased as well. In addition, stimulation of CD4+CD25- cells with hBD-2, -3 and RNAse-7
resulted in the induction of glycoprotein A repetitions predominant (GARP), a transmembrane pro-
tein which is present on the surface of activated Treg. In contrast, psoriasin did not affect the expres-
sion of Treg-associated molecules. These data provide first evidence that similar to their murine
analogues certain human AMP may exert similar immunosuppressive capacities. Through this abil-
ity, human AMP may protect the host from microbial attacks on the one hand, but tame T-cell-
driven reactions on the other hand, thereby enabling an antimicrobial defense without collateral
damage by the adaptive immune system.
058
Molecular characterization of ECP-induced monocyte-derived dendritic cells
K Liu, E Robinson, R Filler, J Lewis, R Tigelaar, R Edelson and M Girardi Dermatology, Yale
University School of Medicine, New Haven, CT
Extracorporeal photopheresis (ECP) in the treatment of cutaneous T-cell lymphoma, GVHD and
autoimmune conditions continues to spur the question of how ECP is capable of inducing immuno-
genicity and tolerance. We previously demonstrated that ECP treatment leads to large-scale con-
version of peripheral blood monocytes into functionally competent leukocytes with dendritic cell
phenotypes, which may play key roles in the immunomodulatory capabilities of ECP. To character-
ize this population of cells on a molecular level, we assessed for differential surface expression of
selected gene-products on monocytes after treatment with a model-ECP apparatus. Four gene-
products (CXCL16, SIRPa, ICAM1, TNFR1) showed significant increases in surface expression after
model-ECP treatment as compared to PBMC (p <0.01 for all). To identify transcription factors (TFs)
expressed by ECP-treated monocytes but not peripheral blood monocytes, rtPCR was performed.
Interactions with platelets during ECP passage was also assessed by using model-ECP plates coated
with low- and high-density platelets. Seven TFs demonstrated increases in mRNA after passage
through the model-ECP plate (ΔRQ range 1.35- 6.78). Increased platelet density induced directional
changes in expression (RQ < 0.5) for VDR, NFkB2, CDKN1A and BCL3. BTBD4, a transcription
factor recently identified as being specifically expressed in classical DCs, demonstrated ~3-fold
increase in expression after treatment. CREM, an important component of cAMP-mediated signal
transduction and possible DC maturation marker, was significantly up-regulated with both platelet
treatments (RQ = 6.78 and 5.9 for low- and high-density platelets, respectively). In summary, pas-
sage through the ECP plate apparatus caused activation of novel surface molecules and transcrip-
tion factors that define and characterize a unique subset of “physiologically-induced” DCs. The
effects of these cells on the immunobiology of ECP treatment will be further elucidated.
059
CD8 T cell epitopes in large and small T antigens of merkel cell polyoma virus exclusively
elicit anti-viral T-cell responses in merkel cell carcinoma patients
R Lyngaa,1 CA Thrue,1 P thor Straten,1 P Nghiem,2 JC Becker3 and SR Hadrup1 1 Center for
Cancer Immune Therapy, University Hospital Herlev, Herlev, Denmark, 2 University of
Washington Dermatology, Fred Hutchinson Cancer Research Center, Seattle, WA and 3
General Dermatology, Medical University of Graz, Graz, Austria
Merkel cell carcinoma (MCC) is a highly aggressive skin cancer with approximately 1600 new cases
in the US each year and the incidence is increasing. Metastatic disease is insensitive to radio- or
chemotherapy. The Merkel cell polyomavirus (MCV) is identified as the main causative agent for
MCC, and together with several reports of spontaneous regression and prognostic value of CD8 T
cell infiltration, is points to the use of immunotherapeutic treatment approaches. The viral onco-
proteins are highly specific tumor targets and foreign antigens that represent the ideal targets for
immunotherapy. However, today our knowledge of T cell recognition is restricted to one HLA-A24
restricted T cell epitope in the Large T antigen. We sat out to map T cell recognition of the polyoma
virus by a broad range of HLA-restriction. We identified potential HLA-binding peptide-sequences
in Large T, Small T and VP1 (capside protein) by in silico prediction, and verified the HLA binding
experimentally among 398 candidate HLA-ligands. 236 verified HLA ligands were selected for T
cell analyses. We analysed peripheral blood from both MCC patients and healthy donors for reac-
tivity against this set of potential MCPyV derived T cell epitopes. We identified responses against
12 sequences from Large and Small T antigens and 23 sequences from VP1. Strikingly, T cell responses
against Large and Small T antigens were found exclusively in MCC patients and not in healthy donors.
We verified the antigen processing and functional recognition of epitopes restricted to HLA.A2, A11
and B7. The sequences that we have identified in this study are prime candidates for T cell based
immunotherapy of Merkel Cell Carcinoma – and importantly this study shows that immune recog-
nition of Large and small T antigens are restricted to Merkel cell carcinoma.
060
The PD-1 pathway is a potential drug target for squamous cell carcinoma in solid organ
transplant recipients
CQ Wang,1 VR Yanofsky,3 H Mitsui,2 JG Krueger,1 D Felsen2 and JA Carucci3 1 Laboratory for
Investigative Dermatology, The Rockefeller University, New York, NY, 2 Department of
Urology, Weill Cornell Medical College, New York, NY and 3 Department of Dermatology,
NYU Langone Medical Center, New York, NY
Immunotherapies with anti-PD-1 and anti-PD-L1 mAb have shown an impressive clinical response
in patients with melanoma, and are currently being tested for other cancers. Squamous cell carci-
noma (SCC) is a significant cause of morbidity and mortality in organ transplant recipients under-
going systemic cyclosporine A treatment, however, the involvement of the PD1/PD-L1 pathway in
these patients is unknown. We therefore sought to determine the expression of the PD-1 pathway
in cutaneous SCC and the potential effect of cyclosporine A on this pathway. Immunohistochemi-
cal staining of PD-1and its ligands (PD-L1& PD-L2) was observed in the stromal region of SCC in
immune competent patients (n=6) as well as in immune-suppressed transplant recipients (n=4), but
not in normal skin of healthy volunteers (n=3). Double immune-fluorescent staining on SCC biop-
sies (n=3) showed the positive expression of PD-L1 on CD11c+ dermal dendritic cells, forming cel-
lular clumps in the SCC stroma. In contrast, no double positive cells were found in normal skin
(n=2). To determine the impact of cyclosporine-A on PD-1 signaling, normal human keratinocytes
(n=3) were treated with cyclosporine-A (100ng/mL) and induction of PD-L2 was observed at both
24h and 48h (p<0.05). In summary, we demonstrated the activation of the PD-1 axis in cutaneous
SCC, and its induction by cyclosporine A. Peripheral tissue expression of PD-1 ligands is important
for mediating immune tolerance and inhibiting the immune response. Thus, the impact of
cyclosporine-A on PD-L2 expression in keratinocytes may underlie the successful immune evasion
of SCC in transplant recipients. Although further functional analysis is required to delineate the role
of PD-1 signaling associated with SCC progression, our data suggest that PD-1 pathway is a poten-
tial target for immunotherapy in transplant recipients with SCC.
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Modulation of CD81 by hypersensitivity reaction inducer drugs
C Boulard,1,2 M Vaillant,1,2 D Picard,1,2 K Perichon,1 B Sabbah,1 B Janela,3 F Tetart,1,2 P Joly,1,2
S Calbo,1 F Caillot1 and P Musette1,2 1 INSERM U905, Normandie Univ, IRIB, Rouen University
Hospital, Department of Dermatology, Rouen, France, 2 Department of Dermatology, Rouen
University Hospital, Rouen, France and 3 Singapore Immunology Network, Agency for
Science, Technology and Research (A*STAR), Singapore, Singapore
CD81 is a widely expressed cell-surface protein involved in many biologic responses inducing the
activation of the immune system and virus entry in the target cells. In B cells, CD81 is a compo-
nent of the CD19/CD21 co-receptor complex that allows B cell activation and Epstein-Barr Virus
(EBV) entry. EBV reactivation is frequently associated to drug reaction with eosinophilia and sys-
temic symptoms (DRESS) which is a severe drug-induced hypersensitivity skin reaction. We previ-
ously show that only the culprit drugs trigger the production of EBV in DRESS patients. Interest-
ingly, recent studies show that CD81 overexpression could be modulated by drugs such as
phenobarbital. Thus, we focused on the drug-induced modulation of CD81 protein expression. B
lymphoblastoid cell lines from 5 DRESS patients and 6 healthy controls were incubated or not with
sulfamethoxazole, valproic acid, carbamazepine, allopurinol, amoxicillin or gentamicin, the latter
being an irrelevant drug which does not induce hypersensitivity reaction. CD81 and CD19 cell sur-
face expression were evaluated with fluorescence activated cell sorter (FACS) analysis. Our results
show that there is no drugs’ effect on the Mean Fluorescence Intensity (MFI) of CD19, which decreases
over time during the culture. On the contrary, the MFI of CD81 is increased by sulfamethoxazole
and valproic acid. However, there is no significant difference between DRESS patients and healthy
controls. In conclusion, these findings suggest that CD81 is a target of certain hypersensitivity reac-
tion inducer drugs, such as sulfamethoxazole and valproic acid, and may facilitate viral entry in B
cells.
063
Human CD141+ dermal dendritic cells integrate danger signals to modulate their function
BR Flutter, N Ali, G Barinaga, I Tosi, E Semenova and FO Nestle St John’s Institute of
Dermatology, King’s College London, London, United Kingdom
As an organ the skin is subject to colonization by a wide range of microorganisms each of which
contain myriad molecules, which may be detected by innate receptors such as Toll-like receptors
(TLRs). Dendritic cells (DCs) are the key sensors of danger signals in the environment, and integrate
these signals to regulate adaptive immune responses. We recently characterised a tissue resident
population of dermal DCs in human skin identified by the expression of CD141 (Chu, Ali et al. J
Exp Med 2012). In the steady state these DCs are capable of cross presenting antigens and direct-
ing immunoregulatory responses via production of IL-10 and induction of regulatory T cells (Treg).
However, the relative contribution of distinct tissue resident DCs to immunity and tolerance remains
poorly understood. Here we isolate the DCs from human skin samples and sort them into three
major populations of cells (CD141+ dermal DCs, CD1c+ dermal DCs and epidermal Langerhans
cells), and analyse their response to TLR ligands and microbial products. In the steady state CD141+
dermal DCs have a unique cytokine response including production of IL-6, IL-23 and IL-10, they
stimulate weak proliferation of alloreactive CD4 T cells and induce potent Treg. However, follow-
ing TLR ligation proliferation of alloreactive CD4 T cells is restored and there is a marked increase
in production of IL-6 and IL-23. In parallel we have been studying monocyte derived vitamin D
induced CD141hi immunoregulatory DCs. Like their skin resident counterparts these DCs upregu-
late IL-6 and IL-23 production in response to LPS and imiquimod and also increase expression of
molecules known to be important in the induction of productive T cell responses including CD80,
CD86 and CLEC9A. These results suggest that under pro-inflammatory conditions CD141+ tissue
resident DCs may be key in switching the response from immunoregulation to immunity, with poten-
tial relevance to protective immune responses of the skin and inflammatory disorders such as pso-
riasis.
065
Differential migration of Langerhans’ cells from patients with early- and late-onset psoriasis
LH Eaton,1 L Chularojanamontri,2 E Theodorakopoulou,2 RB Warren,2 RJ Dearman,1 I Kimber1 and
CE Griffiths2 1 The Faculty of Life Sciences, University of Manchester, Manchester, United
Kingdom and 2 The Dermatology Centre, University of Manchester, Manchester, United
Kingdom
Psoriasis is an immune-mediated inflammatory disease with two distinct ages of onset, defined as
early-onset psoriasis (EOP) and late-onset psoriasis (LOP), presenting, respectively, before and after
40 years (y) of age. Langerhans’ cells (LC) are epidermal dendritic cells that, after activation, migrate
from skin to draining lymph nodes and play roles in initiating and regulating immune responses.
We have shown previously that, in EOP, LC mobilisation is impaired in response to tumour necro-
sis factor (TNF)-α and interleukin (IL)-1β; cytokines that induce 20-30% LC migration in healthy
individuals. In LOP patients, however, intradermal injection of IL-1β induces LC migration, whereas
TNF-α does not. In an ex vivo explant model, unlike healthy individuals, epidermal sheets from EOP
patients did not display spontaneous LC migration. This study sought to characterise spontaneous
LC migration in LOP individuals. In LOP patients (1 male, 3 female; mean age 59.5y; mean age of
onset 48.5y), two 6 mm punch biopsies were taken under local anaesthetic from uninvolved skin
on the buttocks. The epidermal sheet was removed from one biopsy and fixed in acetone immedi-
ately (T0). The other was floated on 500 μl RPMI medium containing 10% foetal calf serum for 24
h before being fixed (T24). The frequency of LC in epidermal sheets was assessed in blinded fash-
ion using fluorescence microscopy. The mean density of LC in the T0 of LOP patients was 592±83
LC/mm2. T24 was significantly lower; 476±57 LC/mm2 (p<0.05). The mean decrease in LC frequency
in T24 compared with T0 was 18.7%, a level comparable with that seen in healthy individuals
(19.6%). This is in contrast to EOP, in which we have previously shown that spontaneous migration
of LC from explanted uninvolved skin is absent or minimal. These data confirm that the explant
model is a useful system to investigate LC migration ex vivo and further highlights the differential
behaviour of LC in EOP and LOP.
064
In vivo induction of human cutaneous inflammation results in the accumulation of neutrophils
expressing RORγ and IL-17, while IL-17+RORγ+ T cells are absent
R Keijsers,1,2 P van Erp,1 H Koenen,2 I Joosten2 and P van de Kerkhof1 1 Department of
Dermatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands and 2
Department of Laboratory Medicine, Laboratory of Medical Immunology, Radboud University
Nijmegen Medical Centre, Nijmegen, Netherlands
Recent, successful clinical trials using antibodies targeting IL-17 in psoriasis support the impor-
tance of IL-17 in the pathophysiology of psoriasis. However, there is some debate concerning the
cell source of IL-17 in the inflamed skin. The objectives of this study were to characterize the IL-17-
producing innate and adaptive cell populations in time, before and during early clinical manifes-
tation of skin inflammation. Therefore, we utilized two established models for the induction of human
skin inflammation in vivo that share many histological features with psoriasis: application of
leukotriene B4 (LTB4) (n=10) and tape stripping (n=10). Biopsies were taken in healthy volunteers
at 5-6 different time-points between 0 and 72 hours and were processed for immunohistochem-
istry. Application of LTB4 first led to an influx of neutrophils, with a peak incidence at t=24-32 hours,
followed by an influx of T cells at t=48 hours. Tape stripping caused an early influx of neutrophils
and T cells at t=16 hours. Presence of mast cells remained steady during the skin inflammatory
process. Characterization of IL-17 associated cells, led to the finding that IL-17 was produced by
neutrophils and mast cells in both models. Notably, only the neutrophils co-expressed the IL-17
associated transcription factor RORγ. Surprisingly, none of the T cell subsets expressed RORγ or IL-
17. These observations challenge the classical opinion that IL-17 is predominantly associated with
T cells in psoriasis. It is attractive to hypothesize that IL-17+/RORγt+ neutrophils might contribute
to the development of psoriasis.
062
Genetic variations in IL6 and IL12B as protective markers for psoriasis
AN Boca,1 M Talamonti,2 M Galluzzo,2 E Botti,2 AD Buzoianu1 and A Costanzo2 1 Department
of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Hatieganu University of
Medicine and Pharmacy, Cluj-Napoca, Romania and 2 Department of Dermatology,
University of Rome Tor Vergata, Rome, Italy
Recent studies associate a number of genetic polymorphisms to psoriasis. In this direction, we aimed
to assess the protective potential of three genetic variants of interleukin genes. In the present case-
control study we genotyped a group of 67 psoriasis patients and 69 healthy subjects for IL6 rs1800795,
IL12B rs3212227 and IL12B rs6887695. All data was than statistically analyzed using SPSS. Statis-
tical significance was present for IL6 rs1800795, IL12B rs6887695 (p=0,001, p=0,028, respectively).
In the case-control analysis, IL6 rs1800795 CC vs. GG carriers showed a strong protection against
the disease (OR=0,072, p=0,018), so did IL12B rs6887695 CC vs. GG carriers (OR=0,198, p=0,025).
Combining these markers in a multivariate analysis increased the protective value to 95,5% for CC
vs. GG in both IL6 rs1800795 and IL12B rs3212227 (p=0,006). Concluding, we report of the minor
alleles of IL6 rs1800795 and IL12B rs6887695 as potentially protective markers for psoriasis. In
daily clinical practice, such markers could be integrated in the management of psoriasis, increas-
ing the accuracy of diagnosis, or offering a more appropriate counseling to patients with familiar-
ity for the disease.
066
Tubacin, a histone deacetylase 6 inhibitor, suppresses contact sensitivity via impairment of
the immune synapse
G Tsuji, N Okiyama, V Villarroel and SI Katz Dermatology Branch, NCI, NIH, Bethesda, MD
Histone deacetylase (HDAC) enzymes affect the acetylation of histones and other cellular proteins
that are therapeutic targets for many diseases. HDAC inhibitors (FDA-approved) have been reported
to have immune modulatory properties as well as anti-cancer effects; however, the mechanism(s)
are largely unknown. HDAC6 deacetylates a unique substrate, α-tubulin, a major cytoskeleton pro-
tein. Since acetylated α-tubulin is involved in cell-cell adhesion and HDAC6 is concentrated at the
immune synapse (IS), the contact site between T cells and antigen-presenting cells, we hypothe-
sized that HDAC6 may be essential for IS function leading to T cell activation. To test this hypothe-
sis, we utilized a murine model of 2,4,6-trinitrochlorobenzene (TNCB)-induced contact sensitivity
and in vitro assays using tubacin, a specific HDAC6 inhibitor. Balb/c mice were given tubacin IP
before sensitization and/or challenge with TNCB. Tubacin (2.0mg/kg) given before challenge, but
not before sensitization, significantly suppressed the ear swelling response (-71.8±10.1%, p<0.05;
U test). In vitro, proliferation of hapten specific T cells obtained from TNCB-sensitized mice and
stimulated with mitomycin-C-treated spleen cells conjugated with 2,4,6-TNBS, a water-soluble ana-
log of TNCB, was inhibited by 5 μM of tubacin (-52.7±3.81%, p<0.05; t-test). To analyze mecha-
nism(s) involved in this suppression, naive T cells were stimulated with anti-CD3/CD28 Ab. Tubacin
(at 4 or 5 μM) inhibited cell proliferation (-47.3±1.06% and -76.1±0.64%, respectively, p<0.05; t-
test). In contrast, tubacin at the same concentrations did not inhibit ionomycin and PMA-induced
cell proliferation. Finally, 5 μM of tubacin inhibited ZAP-70 phosphorylation, an activation marker
of CD3 signaling, in the anti-CD3/CD28 Ab-stimulated T cell proliferation assay (-40.2±5.73%,
p<0.05; t-test), suggesting that inhibition of HDAC6 may impair IS function leading to disruption of
CD3 signaling. These findings suggest that HDAC6 may be a novel target for the treatment of con-
tact sensitivity and other immune-mediated diseases.
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The regulatory T cell population is altered in atopic dermatitis
V Martinz,1 CH Tripp,1 R Gruber,1 D Finke,2 C Heufler-Tiefenthaler,1 H Fiegl,3 M Schmuth1 and
S Dubrac1 1 Department of Dermatology and Venereology, Innsbruck Medical University,
Innsbruck, Austria, 2 Developmental Immunology, Department of Biomedicine, University of
Basel, Basel, Switzerland and 3 Department of Gynecology and Obstetrics, Innsbruck
Medical University, Innsbruck, Austria
Atopic dermatitis (AD) is considered as a dermatologic disease resulting from skin barrier disorders
and overreacting skin immune response. However the role of immunosuppression and especially
of regulatory T cells (Tregs) remains unclear. In this work, we aimed to characterize Tregs in AD
patients and in two mouse models of AD. Adult patients with AD lesions show elevated demethy-
lation of CpG dinucleotides in a conserved region of FoxP3 intron 1 in peripheral blood, which
demonstrates more Tregs exhibiting suppressive function as compared to healthy controls and non-
lesional patients. Similarly, both mouse models i.e. topically treated with vitamin D3 (VitD3) or
overexpressing TSLP under a K14 promotor, exhibit increased ICOS-expressing CD4+ CD25+ FoxP3+
Tregs in skin draining lymph nodes (sdLNs). Moreover, proportions of natural Tregs are increased
compared to induced Tregs, suggesting that AD favors expansion of natural Tregs. Direct upregula-
tion of Tregs by VitD3 was excluded by removal of the application site and instead, skin-derived
dendritic cells (DCs) are required for Treg induction. Indeed, Langerhans cells (LCs) are the first skin-
derived DC subset to reach the sdLN and to induce expansion of Tregs on day 3 of VitD3 treatment,
while numbers of Langerin+ and Langerin- dermal DCs and other DCs were increased only on day
5. However, depletion of Langerin-expressing DCs indicates that other DCs can step in for the induc-
tion of cytokine-producing, largely natural, Tregs in AD. In conclusion, although skin-derived DCs
expand activated Tregs in AD, resulting immunosuppression is unable to counteract the ongoing
skin inflammation.
068
The role of reactive oxygen species produced in XS-106 dendritic cells by the irritant, ben-
zalkonium chloride
D Kim,1 J Je,1 D Byamba,1 S Kim,1 D Shin,1 H Jee,1 J Baek,2 H Cho3 and M Lee1 1 Department of
Dermatology and Cutaneous Biology Research Institute, Yonsei University College of
Medicine, Seoul, Republic of Korea, 2 Department of Dermatology, Gil Medical Center,
Gachon University, Incheon, Republic of Korea and 3 Department of Dermatology,
Kwandong University College of Medicine, Goyang, Republic of Korea
Contact dermatitis is an inflammatory skin condition resulting from cutaneous contact with mate-
rials. Dendritic cells (DCs)-derived reactive oxygen species (ROS) during antigen presentation were
reported to play important roles in the pathogenesis of contact dermatitis. Previously, we have shown
that allergen-induced ROS increase immune responses in XS106 DCs and human monocyte-derived
DCs (MoDCs). However the roles of irritant-induced ROS in XS106 DCs are not fully character-
ized. Therefore, herein, we have evaluated the roles of ROS produced in XS106 DCs by irritant, ben-
zalkonium chloride (BKC). ROS were produced by BKC in XS106 DCs and ROS production was
increased in correlation to the incubation time. When pretreated with GSH, catalase and vitamin
E, ROS productions were blocked. Apoptosis was increased in BKC-treated XS106 DCs in concen-
tration dependent manner. However, antioxidants did not prevent apoptosis which implies that apop-
tosis by BKC is not related to ROS produced by BKC stimulation. Cell surface molecules, such as
CD80, CD86 and MHC II, were expressed on XS106 DCs both before and after BKC treatment
without significant differences. Cytokine production from BKC-treated XS106 DCs was checked by
ELISA. IL-12 and IL-4 secretions were not increased in XS106 DCs by BKC.TNF-α was produced in
XS106 DCs in correlation to the concentration of BKC. TNF-α secretion was blocked by GSH and
vitamin E, but not by catalase. In summary, the role of BKC-induced ROS in XS106 DCs is different
from TNBS-induced ROS. BKC-induced ROS in XS106 DCs do not have a role related to the immune
response but probably only related to inflammation.
069
Human intraepidermal T cells: A phenotypically and functionally distinct population of skin
resident T cells
R Watanabe,1 A Gehad,1 CH Yang,1 JE Teague,1 J Seneschal,2 TS Kupper1 and RA Clark1 1
Department of Dermatology, Brigham and Women’s Hospital, Boston, MA and 2 Department
of Dermatology, Saint-André Hospital, Bordeaux University, Bordeaux, France
In mice, epidermis is colonized by invariant γδ dendritic epithelial T cells and CD8 αβ T cells but
human intraepidermal T cells remain largely uncharacterized. We find that T cells are as numerous
as Langerhans cells in the epidermis of healthy human skin. In contrast to mice, all intraepidermal
T cells (IET) were αβ, γδ T cells were not evident, and both CD4 and CD8 T cells were present, in
a ratio of 3:1. 44% of IET CD4 cells expressed CD103, as compared to 13% in the dermis and cen-
tral memory T cells were rare. IET contained both FOXP3+ Treg and effector T cells. IET had distinct
cytokine profiles with significantly increased TNFα and IL-22 and decreased IL-4 production as com-
pared to human CD4 dermal T cells (DT). IL-17 and IFNγ were elevated but not significantly higher
in IET. In contrast to DT, IET responded poorly to mitogens, showed limited proliferative capacity
and underwent apoptotic cell death, prevented by the caspase inhibitor Z-VAD-FMK, after removal
from the epidermis. We infused allogeneic human CD103- blood T cells into NSG mice grafted
with human foreskin, which lacks resident T cells. Human T cells migrated specifically into the
grafted human skin and T cells within the epidermis upregulated CD103 expression but those in
the dermis did not (17% IET CD103+ vs. 1% DT). Stimulation in direct contact with keratinocytes,
but not in transwells and not with fibroblasts, significantly upregulated CD103 expression on human
blood T cells in vitro. CD103+ IET persisted in CTCL patients treated with alemtuzumab, which
depletes recirculating but not sessile skin T cells, suggesting CD103+ IET do not recirculate. In sum-
mary, we find human epidermis contains a distinct population of nonrecirculating CD103+ intraep-
ithelial lymphocytes that are functionally and phenotypically distinct from other skin T cells and
may play a critical role in protecting the skin from infection.
070
Deciphering the role of Langerin+ Dermal DC in the immune response inducing by skin
scarification (S.S.) with vaccinia virus (VACV)
J Seneschal,1,2 X Jiang1 and T Kupper1 1 Dermatology, Brigham and Women’s Hospital, Boston,
MA and 2 Dermatology and Pediatric Dermatology, National Center for Rare Skin Diseases,
INSERM U 1035, Bordeaux, France
The murine Langerin Diphteria Toxin Receptor (Lang-DTR transgenic mice) allows us to dissect the
relative roles of Langerhans cells (LC, late repopulators) and Langerin+ dermal DC (Ln+dDC, early
repopulations) after administration of diphtheria toxin. Mice skin scarified (s.s.) with VACVova showed
rapid proliferation of OT-1 cells in skin draining nodes, rapid distribution of OT-1 cells to skin by
day 3, peaking at day 7, strong cytotoxicity to ova-expressing tumors (EG7) in vitro, and protection
against tumor growth in vivo. Mice depleted only of LC were indistinguishable from normal mice
in all these parameters. However, mice depleted of both LC and Ln+dDC showed delayed >4 day
proliferation in draining nodes, only 20% of control numbers of skin OT-1 cells at day 7, and poor
in vitro cytotoxicity. However, their ability to induce E and P selectin ligands on OT-1 cells was
unimpaired. A third dermal population of DC exists, that are CD11c+ and Ln-; these were unaf-
fected by our treatments. In tumor growth experiments, mice depleted of LC and Ln+dDC still showed
significant delay in tumor growth (300mm3 at day 3 in normal mice, vs day 21 in LC and Ln+dDC
deficient mice). We therefore conclude that Ln+dDC’s, and LC play a non-dominant role in tumor
immunity in this model, and that Ln-DC and lymph node resident DC play a pivotal role. The major
role of Ln+dDC may be in protection against acute viral infection, while other Ln-DC’s may play a
more important role in tumor rejection.
071
Merkel cell carcinoma-specific T cells fluctuate with tumor burden and express therapeuti-
cally targetable PD-1 and Tim-3 exhaustion markers
OK Afanasiev,1 L Yelistratova,1 N Miller,1 K Nagase,1 K Paulson,1 J Iyer,1 D Ibrani,1 D Koelle1,2 and
P Nghiem1 1 Medicine/Dermatology/Pathology, University of Washington, Seattle, WA and 2
Fred Hutchinson Cancer Research Center, Seattle, WA
Purpose: The persistent expression of Merkel cell polyomavirus (MCPyV) oncoproteins in Merkel
cell carcinoma (MCC) provides a unique opportunity to characterize immune evasion mechanisms
in human cancer. We isolated MCC-specific T cells and determined their frequency, functional sta-
tus and response to inhibitory receptor blockade. Experimental Design: Multi-parameter flow cytom-
etry panels and HLA/peptide tetramers were used to identify and characterize T cells from tumors
(n=7) and blood (n=18) of MCC patients and control subjects (n=10). PD-1 ligand (PD-L1) and
CD8 expression within tumors were determined using mRNA profiling (n=35) and immunohisto-
chemistry (n=13). Results: MCPyV-specific CD8 T cells were detected directly ex vivo from the blood
of 7 of 11 (64%) patients with MCPyV-positive tumors. In contrast, 0 of 10 control subjects had
detectable levels of these cells in their blood (p<0.01). MCPyV-specific T cells in serial blood spec-
imens increased with MCC disease progression and decreased with effective therapy. MCC-spe-
cific CD8 T cells expressed higher levels of both PD-1 and Tim-3 inhibitory receptors compared to
T cells specific to other human viruses (p<0.01). PD-L1 was present in 9 of 13 (69%) MCCs and its
expression was correlated with CD8 lymphocyte infiltration. Antibodies targeting these inhibitory
receptors augmented MCPyV-specific T cell cytokine production in response to the cognate anti-
gen. Conclusion: MCC-specific T cells expand with tumor burden and show evidence of inhibition
by PD-1 and Tim-3 exhaustion mechanisms. Reversal of these inhibitory pathways is therefore a
promising therapeutic approach for this cancer.
072
Propionibacterium acnes induced IL-17 response in acne vulgaris: A potential inflammatory
response targeted by all trans retinoic acid and vitamin D3
GW Agak,1 M Qin,1 J Nobe,1 M Kim,2 S Krutzik,1 G Hermes1 and J Kim1 1 Department of
Medicine, Division of Dermatology, David Geffen School of Medicine, UCLA, Los Angeles, CA
and 2 Department of Medicine, Dankook University, Dankook, Republic of Korea
Acne vulgaris is the most common skin disorder affecting millions of people worldwide and inflam-
mation resulting from immune responses targeting P. acnes plays a significant role in its pathogen-
esis. Our recent findings reveals that, P. acnes is a potent inducer of Th17 and Th1, but not Th2
responses in human PBMCs. P. acnes stimulated expression of genes known to directly signal Th17
responses including IL-17A, RORα, RORc, IL-17RA and IL-17RC. The subset of T cells identified to
secrete IL-17 was primarily CD4+ and not CD8+ T cells. Supernatants from P. acnes-stimulated
PBMCs were sufficient to promote the differentiation of naïve CD4+CD45RA T cells into Th17
cells. Furthermore, we found that the combination of IL-1β, IL-6 and TGF-β neutralizing antibod-
ies completely inhibited IL-17 production. Importantly, we demonstrate that IL-17-expressing cells
were present in skin biopsies from acne patients but not from normal donors suggesting that IL-17-
induced inflammation may have clinical relevance. Finally, we found that both all-trans retinoic
acid (ATRA) and the biologically active form of vitamin D3 (1,25D3) inhibited P. acnes-induced
Th17 differentiation. Together, our data suggest that IL-17 may play a role in acne pathogenesis and
that both ATRA and 1,25D3 could be effective tools to modulate Th17-mediated diseases such as
acne.
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Efficacy of RG1-VLP vaccination against genital and cutaneous human papillomaviruses in
vitro and in vivo
C Schellenbacher,1 K Kwak,2 S Shafti-Keramat,1 B Huber,1 C Jindra,1 R Roden2 and R Kirnbauer1
1 Dermatology, Medical University Vienna, Vienna, Austria and 2 Pathology, Johns Hopkins,
Baltimore, MD
Licensed human papillomavirus (HPV) vaccines, based on virus-like particles (VLP) self-assembled
from major capsid protein L1, prevent infection with HPV16 and 18, which cause 70% of cervical
carcinomas and a subset of other genital and oro-pharyngeal cancers. However, they may not pro-
tect against infections with less prevalent mucosal or cutaneous HPV. In contrast immunizations
with minor capsid protein L2 induce low-titer but potentially cross-neutralizing antibodies. We have
previously generated chimeric RG1-VLP by genetic insertion of HPV16L2 amino acids 17-36 (RG1)
within the DE-surface loop of HPV16 L1. Vaccinations induced cross-neutralizing antibodies against
HPV16/18/31/45/52/58/6/11/5. Immunization of 10 rabbits with RG1-VLP adjuvanted with human-
applicable alum-MPL induced robust L2 antibodies (ELISA titers 2,500-12,500). Antisera cross-
neutralized mucosal high-risk HPV26/33/35/39/68/59/68/73/69/53/34, low-risk
HPV6/11/32/40/44/70, and cutaneous HPV2/27/3/76, by pseudovirion- or native virion-based
neutralization assays (titers 25-1,000). Boostable antibody titers over 1 year and ELISPOT assays
demonstrated the induction of B-cell-memory and CTL responses. Using a mouse genital challenge
model, passive transfer with 20μl RG1-VLP immune serum efficiently protected mice against PsV
infection with hr HPV16/18/45/31/33/52/58/35/39/51/59/68/56/73/26/53/66/34 and lr HPV6/43/44.
RG1-VLP is a promising new generation HPV vaccine with broad-spectrum efficacy against mucosal
and cutaneous types.
075
Development and functional competence of dermal dendritic cells in the human fetus
M Haniffa,1 A Shin,2 D Low,2 N McGovern,1 P Wasan,2 M Poidinger,2 A Larbi,2 M Collin,1
C Schuster,3 A Elbe-Burger,3 M Choolani,4 J Chan4 and F Ginhoux2 1 Institute of Cellular
Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, 2 Singapore
Immunology Network, Singapore, Singapore, 3 Medical University of Vienna, Vienna, Austria
and 4 National University of Singapore, Singapore, Singapore
Dendritic cells (DCs) are critical regulators of immune responses to pathogens, tumours and vac-
cines, and tolerance to self. Immunological competence in the human fetus is poorly understood
with scant attention paid to the contribution of fetal DC network to tolerance and immunity. Our
study aims to map the development and functional maturity of DCs in the human fetal dermis and
how this impacts immune competence. Flow cytometry analysis of fetal skin revealed the presence
of three myeloid DC subsets characterised by the expression of CD141, CD1c and CD14 from 12
weeks of gestation. These subsets correspond phenotypically to the adult cutaneous DC comple-
ment, although the frequency of CD141+ DCs was higher in fetal skin. Gene expression profile of
FACS-purified DC subsets from 18-22 weeks fetal skin and spleen were obtained by microarray.
Comparative transcriptomics analysis showed temporally conserved alignment of fetal CD141+,
CD1c+ and CD14+ DCs with their respective adult counterparts from skin and blood. These find-
ings highlight the early establishment of a comprehensive cutaneous DC network in the human
fetus. Ongoing studies are focused on dissecting their specific immunological functions and com-
petence.
077
The protective capacity of CD8+ TRM cells in distant skin after cutaneous virus infection
X Jiang and T Kupper Dermatology, Brigham and Women’s Hospital, Boston, MA
We have previously shown that repetitive infections of skin at different sites leads to an accumula-
tion of protective T cells that encompass all sites of skin, including those distant from the infected
sites. Additional central memory cells also accumulate in lymph nodes. These protective skin hom-
ing T cells presumably move out of lymph nodes draining the infected skin, enter the blood stream,
and are distributed throughout the body, where they preferentially home to sites that express low
constitutive levels of their ligands—E selectin, CCL19, and ICAM-1, all of which are expressed on
normal skin. In order to test this theory, we repetitively infected a mouse, and thirty days later we
parabiotically joined it to a normal mouse. After four weeks, parabionts were separated, rested for
two weeks, and challenged with vaccinia virus (VACV) on distant skin. The previously infected para-
biont rapidly cleared VACV infection from distant skin, while the uninfected parabiont, although it
contained abundant central memory T cells and antibody, could not efficiently clear infection. This
indicates that prior skin infection at different sites in the same organ by the same pathogen multi-
ple times through a subject life leads to subsequent resistance to infection throughout that organ,
in a process mediated by skin-resident memory T (TRM) cells generated by multiple infections.
076
Microanatomical dissection of the human dermis: The relationship between antigen present-
ing cells, lymphatic and blood vessels
X Wang,1 N McGovern,1 M Windebank,1 S Pagan,1 V Bigley,1 A Shin,2 F Ginhoux,2 H Lim,3
V Angeli,3 M Collin1 and M Haniffa1 1 Newcastle University, Newcastle upon Tyne, United
Kingdom, 2 Singapore Immunology Network, SIngapore, Singapore and 3 National University
of Singapore, SIngapore, Singapore
Dendritic cells (DCs) and macrophages (Macs), collectively defined as antigen presenting cells (APC),
are abundant in the human dermis. DCs and Macs maintain immune homeostasis and generate
rapid responses to inflammatory challenges. The dermis has a rich supply of blood and lymphatic
vessels that enable leukocytes to enter and migrate from the skin during steady state and inflam-
mation. Hitherto, there is limited data on the spatial relationship of APCs, lymphatic and blood ves-
sels in situ and the temporal demonstration of DC migration via skin lymphatics. We performed
immunofluorescent microscopy analysis of serial skin sections cut with a dermatome and demon-
strate the presence of small LYVE1+ initial lymphatic vessels and CD31+ capillaries 100-150 μm
beneath the skin surface. Larger well-connected initial lymphatic and blood vessels were visible at
a depth of 250 μm followed by LYVE1lo Podoplanin+ collecting vessels with valves in the luminal
surface at >300 μm. DCs and Macs were peri and intervascularly distributed in the papillary der-
mis. However, DCs were more abundant apically while Macs dominated the lower section of the
papillary dermis. In contrast, CD3+ T cells were primarily localised in the lower papillary dermis
and entirely perivascular in distribution. We assessed DC lymphatic migration by serial time point
analysis and live microscopy of skin cultured ex vivo. Very few HLA-DR+ DCs were detected
within lymphatic channels at t=0 but their frequency increased after 24 and 32 hours of culture.
FXIIIa+ macrophages were never observed within the lymphatic vessels. Our findings on the dis-
tinct microanatomical network of APCs, lymphatic and blood vessels speculate the existence of
functional immune niches within the dermis. The dynamic studies of DC migration via lymphatics
will contribute towards the knowledge base required to facilitate future DC-based immunotherapy
strategies.
074
Endothelial activation in localized oedema with sclerodermatous evolution in skin chronic
graft versus host disease
M Tardieu,1 JD Bouaziz,1 R Peffault de La Tour,2 H Le Buanec,1 M Robin,2 A de Masson,1
A Bergeron,3 M Rybojad,1 A Bensussan,1 G Socie2 and M Bagot1 1 Dermatology and
Immunology, Saint Louis Hospital and INSERM U976, Paris, France, 2 Bone Marrow
Transplant Unit, Saint Louis Hospital, Paris, France and 3 Pneumology, Saint Louis Hospital,
Paris, France
Clinical forms of skin chronic Graft Versus Host Disease (cGVHD), an allo-immune reaction after
hematopoietic stem cell transplantation, are mainly lichenoid or sclerodermatous. Up to date, oede-
matous forms of skin cGVHD have never been described. We retrospectively describe localized
skin oedema with rapid sclerodermatous evolution in 5 patients in the setting of cGVHD. Mean
Soluble Vascular Adhesion Molecule-1 (sVCAM-1) concentration, as measured by ELISA, in oede-
matous cGVHD was 2045 ng/ml, versus 282 ng/ml in sclerodermatous cGVHD, 526 ng/ml in allo-
graft patients without cGVHD and 360 ng/ml in control healthy donor group (p<0,05 for all three
measures). In lichenoid cGVHD, mean sVCAM level was 1612ng/ml. These results suggest an endothe-
lial activation in oedematous and lichenoid skin cGVHD which may be the first phase of a more
complex process sometimes leading to skin fibrosis. Though rare, this reversible clinical form of
oedematous skin cGVHD must be recognized and treated before sclerosis is formed.
078
Dermal γδ T cells and their role in contact hypersensitivity
X Jiang, J Geddes, O Gaide, M Yoo and T Kupper Dermatology, Brigham and Women’s Hospital,
Boston, MA
Recent studies have shown that γδ T cells not only exist in murine epidermis (Dendritic Epidermal
T cells, DETC) but also populate in the dermis. DETC have been well-studied for decades. How-
ever, little is known about the homeostasis of dermal γδ T cells and their roles in skin immune
responses such as in contact hypersensitivity (CHS). In this study, we first analyzed the phenotype
of dermal γδ T cells and found they have a memory phenotype (CD62L-CD44hi), express high lev-
els of CD69, CD103, and E- and P-selectin ligands, but have heterogeneous γδTCR repertoires (30%
TCR Vγ2+). Upon activation, these dermal γδ T cells produce large amounts of IL-17 and IL-22.
GFP+:GFP- parabiosis experiments further showed that dermal γδT cells are constantly circulating,
whereas DETC are non-recirculating. In order to explore their roles in CHS, we first sensitized and
challenged TCR δ-/- mice with 2, 4-dinitrofluorobenzene (DNFB). A remarkable reduction of CHS
responses in these pan-γδ T cell-deficient mice was observed, suggesting γδ T cells play a pivotal
role in CHS responses. We next generated dermal γδ T cell-deficient chimeric mice by bone mar-
row transfer with injection of neonatal thymocytes to irradiated mice. These mice were then sensi-
tized and challenged with DNFB and CHS responses were measured. Our results showed that CHS
responses in dermal γδ T cell-deficient mice was significantly lower than that of wild type mice,
demonstrating dermal γδ T cells do participate in CHS responses. Furthermore, we depleted IL-17-
producing Vγ2+ dermal γδ T cells by using neutralizing antibodies and found that CHS responses
were also significantly reduced in these mice. Therefore, our data suggest that circulating IL-17-
producing γδ T cells in dermis play an important role in establishing CHS response.
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IL-22 single-producing CD4+ T lymphocytes: Candidate effector cells in acute cutaneous graft-
versus-host disease
C Bruggen,1 I Klein,1 H Greinix,2 W Bauer,1 Z Kuzmina,2 W Rabitsch,2 R Knobler,3 G Stingl1 and
G Stary1 1 Dept. of Dermatology, DIAID, Med. Univ. of Vienna, Vienna, Austria, 2 Dept. of
Internal Medicine 1, Bone Marrow Transplantation, Med. Univ. of Vienna, Vienna, Austria and
3 Dept. of Dermatology, Div. of General Dermatology, Med. Univ. of Vienna, Vienna, Austria
Graft-versus-host disease (GVHD) is the major clinical complication of allogeneic hematopoietic
stem cell transplantation (HCT) and can present in an acute and chronic form. The question whether
similar or different pathomechanisms are operative in acute (aGVHD) and chronic GVHD (cGVHD),
has not yet been resolved. To address this issue, lesional skin biopsies were obtained from aGVHD
(n=25) and cGVHD (n=16) patients. The cellular infiltrate was assessed by immunofluorescence
stainings; interleukins and chemokines were measured by real-time RT-PCR. Cytokine secretion pro-
files of stimulated T cells from collagenase-digested lesional skin biopsies were analyzed by intra-
cellular flow cytometry. While CD4+ and CD8+ T cells dominated the inflammatory infiltrate in
both acute and cGVHD, the analysis of the quality of the T cell-mediated immune response revealed
striking differences. In aGVHD lesions, there was a predominance of Th2 cytokines (IL-4, IL-13)
and chemokines (CCL17, CCL22). In accordance with these findings, we observed an increase of
IL-4-producing T cells in aGVHD lesions. Remarkably, levels of IL-22 mRNA were highly increased
in aGVHD but not in cGVHD, while IL-17 was up-regulated in both forms of the disease. Cytokine-
producing cutaneous T cells in aGVHD lesions showed an increased percentage of IL-22 and IL-
17 single-producing CD4+ T cells. The immune response occurring in cGVHD skin lesions was
characterized by a Th1/Th17 pattern, as evidenced by a relative increase of Th1 chemokines (CCL5,
CCR5, CXCL9, CXCL10) as well as Th1/Th17 cytokines (IFN-γ, IL-12/IL-23p40, IL23p19). Our find-
ings shed new light on the pathomechanisms operative in the different manifestations of cutaneous
GVHD and, furthermore, identify molecular signatures to more accurately predict and verify the
occurrence of this disease.
080
Global circulating CD4+ and CD8+ T cells are more differentiated in old melanoma patients
compared to healthy controls
JA Seidel,1 N Riddell,1 S Henson,1 M Vukmanovic-Stejic,1 M Rustin,2 F Nestle,3 K Lacy3 and
A Akbar1 1 Infection and Immunity, University College London, London, United Kingdom, 2
Dermatology, Royal Free Hospital, London, United Kingdom and 3 Genetics and Molecular
Medicine, Kings College London, London, United Kingdom
Melanoma is highly immunogenic but disease progression occurs despite the presence of tumour
specific T cells. Constant antigen exposure may drive the melanoma specific T cells to an end-
stage, as is the case in some chronic virus infections such as CMV. This is particularly pertinent
amongst the elderly where melanoma incidence and mortality are highest. This study sought to assess
T cell differentiation in melanoma patients aged 65 years and above. Flow cytometry was used to
analyse T cell differentiation (CD27 and CD45RA expression) and CMV T cell responses in PBMCs
of stage I – III melanoma patients and age matched healthy controls. Compared to the controls,
melanoma patients had an inverted CD4:CD8 ratio. In the CD4+ T cell compartment there was a
significant decrease in naïve (CD27+CD45RA+; p<0.005) cells that was accompanied by an increase
in the central memory (CD27+CD45RA-; p<0.005) and effector memory (CD27-CD45RA-; p<0.05)
fractions. Among the CD8+ T cells a reduction in central memory cells (p<0.05) and an increase in
effector memory cells re-expressing CD45RA (CD27-CD45RA+; p<0.05) was observed. These trends
were CMV independent and likely to be a true attribute of melanoma burden. However, no signif-
icant increase in frequency and differentiation of specific CD8+ T cells against Melan-A and NY-
ESO-1 could be measured by MHC dextramers among the HLA-A2+ participants. In summary, global
circulating CD8+ T cells are driven towards an end-stage in old melanoma patients. This is a process
which is partially reversible and could be exploited as a therapeutic target.
081
TIM-3 does not act as a receptor for galectin-9
J Leitner,1 K Grabmeier-Pfistershammer,3 A Rieger,3 W Pickl,2 G Zlabinger2 and P Steinberger1 1
Division of Immune Receptors and T cell activation, Institute of Immunology, Center for
Pathophysiology, Infectiology and Immunology, Medical University of Vienna,, Vienna,,
Austria, 2 Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology,
Medical University of Vienna,, Vienna, Austria and 3 Division of Immunology, Allergy and
Infectious Diseases, Department of Dermatology, Medical University of Vienna, Viena, Austria
T cell immunoglobulin and mucin protein 3 (TIM-3) is a type I cell surface protein that was origi-
nally identified as a marker for murine T helper type 1 cells. TIM-3 was found to negatively regu-
late murine T cells responses and galectin-9 was described as a binding partner that mediates T cell
inhibitory effects of TIM-3. Moreover, it was reported that like PD-1 the classical exhaustion marker,
TIM-3 is up-regulated in exhausted murine and human T cells and TIM-3 blockade was described
to restore the function of these T cells. Here we show that the activation of human T cells is not
affected by the presence of galectin-9 or antibodies to TIM-3. Furthermore, extensive studies on the
interaction of galectin-9 with human and murine TIM-3 did not yield evidence for specific binding
between these molecules. Moreover, profound differences were observed when analysing the expres-
sion of TIM-3 and PD-1 on T cells of HIV-1 infected individuals: TIM-3 was expressed on fewer
cells and also at much lower levels. Furthermore, whereas PD-1 was preferentially expressed on
CD45RA-CD8 T cells, the majority of TIM-3-expressing CD8 T cells were CD45RA+. Importantly,
we found that TIM-3 antibodies were ineffective in increasing anti-HIV-1 T cell responses in vitro,
whereas PD-L antibodies potently reverted the dysfunctional state of exhausted CD8 T cells. Taken
together our results are not in support of an interaction between TIM-3 and galectin-9 and yield no
evidence for a functional role of TIM-3 in human T cell activation. Moreover, our data indicate that
PD-1 but not TIM-3 are promising targets to ameliorate T cell exhaustion.
082
DEC-205 targeted nanoparticles for improved DC-based antigen delivery and cross-presen-
tation
S Saluja,1 D Khalil,1 E Robinson,1 F Sharp,2 T Fahmy,2 R Tigelaar,1 R Edelson1 and D Hanlon1 1
Dermatology, Yale, New Haven, CT and 2 Biomedical Engineering, Yale, New Haven, CT
Nanoparticles (NP) prepared from the biodegradable polymer poly(D, L-lactide-co-glycolide) (PLGA)
have been extensively used in clinical settings for drug delivery and are currently the subject of
intense investigation as antigen (Ag) delivery vehicles for vaccine applications. The goal of our
present work is to increase the potency of dendritic cell (DC)-based anti-tumor vaccines to over-
come inherent limitations in Ag stability and cross-presentation. Here we describe a nanoparticu-
late delivery system with the ability to simultaneously carry a high density of protein-based Ag while
displaying DC targeting ligands on its surface. Utilizing a targeting motif specific for the DC-asso-
ciated surface ligand DEC-205, we show that targeted NP encapsulating a MART-1 peptide epitope
are both internalized and cross-presented with significantly higher efficiency than unlabelled or iso-
type control NP. In addition, utilizing a combination of confocal, electron microscopy and
Imagestream analysis to determine intracellular localization of incorporated NP, we report that DEC-
205 labeled NP rapidly escape from the DC endosomal compartment and do not co-localize with
markers of early (EEA-1) or late endosome/lysosome (LAMP-1). This indicates that encapsulated Ags
delivered by NP may have direct access to the cytoplasmic MHC Class I loading machinery, over-
coming the need for “classical” cross-presentation and facilitating heightened DC stimulation of
anti-tumor CD8+ T cells. Finally, preliminary data utilizing CpG oligonucleotide-labeled NP also
indicated that these reagents can act as “multifunctional” Ag carriers, delivering both Ag and adju-
vant in the same delivery vehicle to maximize DC immunostimulatory capacity. These results indi-
cate that this delivery system provides a flexible and versatile methodology to deliver tumor-asso-
ciated Ag to DC with high efficiency and with the possibility of simultaneously targeting virtually
any DC stimulatory motif.
083
Subcutaneous immunization to HIV gag is potentiated by Flt3L and develops through classi-
cal rather than migratory dendritic cells
N Anandasabapathy,1,2,3 R Feder,2 MP Longhi,2,3 S Mehandru,2,3 S Mollah,4 C Cheong,2,3
D Ruane,2 L Brane,2 A Teixiera,2 J Dobrin,2 O Mizenina,2 B Clausen5 and R Steinman2,3 1
Dermatology, Brigham and Women’s Hospital, Boston, MA, 2 Laboratory of Cellular
Physiology and Immunology, Rockefeller University, New York, NY, 3 Christopher H. Browne
Center for Immunology and Immune Diseases, Rockefeller University, New York, NY, 4
Hospital Informatics, Rockefeller University, New York, NY and 5 Immunology, Erasmus MC,
University Medical Center, Rotterdam, Netherlands
Immune modulatory agents are needed to potentiate subcutaneous (s.c.) vaccination and improve
T cell immunity. In this study, we evaluated the dendritic cell (DC) hematopoietin, Flt3L and HIV
gag protein immunization. Flt3L was detected in serum early after protein vaccine immunization
to HIV gag with adjuvant. Flt3L treatment improved the T cell response to s.c. protein vaccination
by 4.5 fold, and deletion of Flt3 reduced this by 50%. Flt3L enhanced CD4+ and CD8+ IFNγ effec-
tor responses, proliferation, and humoral immunity to gag, with markedly improved mucosal immu-
nity in the lungs and lamina propria. Administration of Flt3L expanded several tissue migratory DC
(migDC) populations that capture and traffic antigens to the skin-draining lymph node (LN), in
addition to LN-resident classical (cDC) and plasmacytoid (PDC) DC. However, in contrast to prior
data supporting a role for both migDC and LN-resident subsets in s.c. vaccination, surprisingly we
observed DC migrating from the skin were not required for immunity, and could temper the immune
response. These results indicate that with a protein vaccine, the immune response to protein vac-
cine is controlled by the resident or cDC in the lymph node.
084
The dual RAR and RXR agonist alitretinoin modulates leukocyte recruitment pathways and
suppresses dendritic cell functions in vitro and in vivo
A Kislat,1 S Meller,1 R Mota,1 BA Buhren,1 PA Gerber,1 E Bünemann,1 U Wiesner,1 T Ruzicka2 and
B Homey1 1 Dermatology, Heinrich-Heine University Hospital, Düsseldorf, Germany and 2
Dermatology, Ludwig-Maximilians-University Munich, München, Germany
Retinoids have shown beneficial effects in treatment in a variety of diseases. The effects of retinoid
acids are mediated by binding to retinoic acid receptors (RAR) and the retinoic X receptors (RXR).
Alitretinoin, a retinoid binding to both RAR and RXR, demonstrated significant efficacy in the treat-
ment of chronic hand eczema. To investigate the mode of action of alitretinoin in vitro and in vivo
we analyzed structural cells as well as leukocyte subsets and performed a clinical study determin-
ing the skin-homing phenotype and activation status of leukocytes before and under treatment with
alitretinoin. In direct comparison with the RAR agonist acitretin, alitretinoin showed markedly
enhanced suppression of chemokine production in keratinocytes as well as inhibition of dendritic
cell maturation and activation. Moreover, the T cell-activating capacity of alitretinoin-treated den-
dritic cells was significantly lower than those treated with acitretin. In vivo, patients undergoing
altitretinoin treatment showed a marked downregulation of the “skin-homing” abilities of effector
T cells. Furthermore, mixed leukocyte reactions in patients were significantly reduced during
alitretinoin therapy. Taken together, these results suggest that the dual RAR and RXR agonist alitretinoin
is superior to the RAR agonist acitretin in modulating skin inflammation.
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Granzyme B plays a central role in delineating subsets and functional differences in human
Tregs in blood and skin
CM Baecher-Allan,1,2 M Manohar,1 S Bhela,2 C Kempsell,1 M Dominguez-Villar,3 R Fuhlbrigge,1
R Clark,1 T Kupper1 and H Weiner2 1 Dermatology, Brigham and Women’s Hospital, Boston,
MA, 2 Neurology, Brigham and Women’s Hospital, Boston, MA and 3 Neurology, Yale, New
Haven, CT
In the study of human Tregs, the cells are most commonly isolated from the blood. These Tregs have
been shown to exhibit defective suppression when isolated from patients with a large number of
different autoimmune diseases. When isolating Tregs from the blood, we demonstrate that they basi-
cally belong to three functionally distinct Treg populations. The most striking feature that distin-
guishes these Treg populations is how the cells respond to, or utilize Granzyme B (GzmB). To clar-
ify the role that GzmB plays in Treg biology, we examined its role in suppression ex vivo by three
populations of human CD25hiFoxP3+ Tregs from the circulation. We show that one subset of Tregs
expresses and utilizes GzmB to suppress by killing, while the two other Treg populations typically
lack GzmB and are inhibited by its activity. Thus, although GzmB has been described to represent
a component of the Treg suppressive repertoire, we show that it actually inhibits suppression by the
majority of circulating FoxP3+Tregs. Whether GzmB would negatively impact Treg suppression,
depends on the type of Treg that is involved in the specific interaction at the site of immune-regu-
lation. As we show that IL-6 induces human CD4 T cells to express GzmB, and that GzmB con-
tributes to the Treg resistance exhibited by responder T cells derived from autoimmune patients, we
propose that GzmB may play a novel role in regulating the activity of specific subsets of human reg-
ulatory T cells. Furthermore, as many of the cells in skin can express GzmB and IL-6, it is crucial to
understand how the Tregs of the skin differ from those in the circulation and the role they may play
in skin autoimmunity and cancer.
087
Assessment of nickel sensitivity using a T-cell immune function assay
G Honari,1 B Yen-Lieberman2 and JS Taylor1 1 Dermatology, Cleveland Clinic, Cleveland, OH
and 2 Clinical pathology, Cleveland Clinic, Cleveland, OH
We conducted a pilot investigation of an adenosine triphosphate (ATP) based in-vitro assay for
diagnosing nickel sensitivity, one of the most common causes of contact allergy, using a T-cell
mediated Immune response assay (Cylex Inc., Columbia, Maryland). While patch testing is the gold
standard to diagnose nickel sensitivity, cytokine and lymphocyte proliferation assays have been stud-
ied to monitor T-cell immune status. We utilized this ATP based assay to measure T-cell activation
in the presence of nickel in CD3 lymphocytes. A total of 8 individuals were enrolled following patch
testing, 4 patients with positive reactions to nickel, and 4 controls with negative reactions. Whole
blood samples from each person were collected into sodium heparin vacutainer tubes and tested
within 10 hours. The whole blood was added to a microtiter well and incubated with Con A and
tetanus antigens as positive controls, blood alone as baseline, and 100, 75, 50, 25 and 12.5 microM
solutions of nickel sulfate hexahydrate (NiSO4.6H2O) to determine a dose response curve. Fol-
lowing incubation for 15 to 18 hours in a 37°C, 5% CO2 incubator, CD3 cells were selected using
magnetic particles coated with anti-human CD3 monoclonal antibody, washed to remove residual
cells, and lysed to release intracellular ATP. ATP was measured with a luciferin/luciferase system
and a luminometer (Berthold, Knoxville, TN). An upward trend of ATP values from baseline was
observed in all 4 patients with nickel sensitivity. Increase in ATP values varied widely from 6.72
fold to 1.04. One patient with the strongest patch test reaction had the highest increase in ATP val-
ues (from 85 to 571 ng/ml). Optimum responses were seen with 25 and 50 microM solutions. ATP
values did not follow specific trends in controls. Limiting factors of this study are the small cohorts,
limited number of lymphocytes per microwells and using a non-specific marker (CD3) for memory
T cells. To our knowledge this is the first attempt to introduce ATP-release assays for in-vitro diag-
nosis of metal sensitivity.
089
Melanoma-silencing through CD4+ T helper (Th1) cell cytokine-induced senescence
C Boss,1 S Kayser,2 T Feuchtinger2 and M Röcken1 1 Dermatology Hospital, University of
Tübingen, Tübingen, Germany and 2 Children’s Hospital, University of Tübingen, Tübingen,
Germany
Adoptive T-cell transfer is a promising therapeutic option for patients with metastatic malignant
melanoma. Recent evidence suggests that CD4+ T helper (Th1) lymphocytes are of great impor-
tance for those therapeutic strategies. Besides melanoma killing, the secretion of IFN-γ and TNF-α
by Th1 lymphocytes seems to be crucial for efficient tumor control. Yet the mechanisms underlying
T cell-mediated control of melanoma growth remain enigmatic. To analyse the effects of the com-
bined application of IFN-γ and TNF-α, we treated a panel of melanoma cell lines with these two
cytokines. By FACS-analysis we found that IFN-γ and TNF-α can cause apoptosis and various types
of cell cycle arrest, including a predominant G0/G1 arrest. In some melanomas the cell cycle arrest
remained stable over >5 passages after withdrawal of IFN-γ and TNF-α, what defines senescence.
Moreover, the cells had a senescence-associated secretory phenotype with the production of IL-6,
IL-8, IP-10 and CCL-2. Thus, the two Th1-cytokines induced senescence in various melanomas, as
defined by stable growth arrest and functional phenotype. To investigate whether it is possible to
generate melanoma-specific Th1 cells, that are capable to drive melanomas into senescence under
therapeutic conditions, we developed a protocol to induce melanoma-antigen specific Th1 lym-
phocytes. We primed peripheral blood mononuclear cells with a NY-ESO-1 peptide mix and devel-
oped stable Th1 cell lines. We restimulated the Th1 cells with NY-ESO-1 and harvested the super-
natant. We incubated various melanomas with the T cell supernatant and analyzed the effect of this
supernatant on the melanoma cell cycle. The supernatant induced both apoptosis and cell cycle
arrest, including a G0/G1 arrest as seen in senescent cells. Thus, melanoma-specific Th1 cells can
be generated that produce cytokines driving human melanomas in a senescence–defining stable
growth arrest. This seems to be of great relevance, as modern immunotherapies rather induce sta-
ble growth arrest in vivo than complete cancer eradication.
088
Genetic or chemical RORγ blockade profoundly suppresses hapten mediated contact hyper-
sensitivity responses
R Purwar,1 L Solt,2 A Jetton,3 T Burris,2 VK Kuchroo,1 R Clark1 and T Kupper1 1 Brigham and
Women’s Hospital/Harvard Medical School, Boston, MA, 2 The Scripps Research Institute,
Jupiter, FL and 3 NIEHS, NIH, Triangle Research Park, NC
Retinoid related orphan receptor-gamma (RORγ) is a lineage specific transcription factor for the
Th17 cell generation. Pathogenic Th17 cells that produce IL-17, IL-22 and express IL-23R are local-
ized in the inflamed skin of psoriasis and allergic contact dermatitis patients. While critical roles of
IL-17 are reported in hapten induced contact hypersensitivity (CHS), roles of RORγ as well as Th17
cells in the development of CHS responses have never been directly assessed. In addition, selec-
tive blockade of IL-17 alone moderately suppresses CHS immune reactions. Here we demonstrate
that deficiency of RORγ inhibits the expression of IL-17 together with other Th17 related genes (IL-
22 and IL-23R), and therefore profoundly suppresses the development of CHS immune reactions in
a murine model of hapten induced CHS. The decrease in inflammation correlated with fewer total
lymphocytes, T cell, and neutrophil infiltration to the site of skin inflammation. Interestingly, there
was comparable CHS induced ear inflammation in Tbet-/-bone marrow chimeric mice (Tbet-/-ch)
and TNFα-/- ch mice, which were deficient in Th1 cells and TNFα+T cells respectively. However,
there was moderate suppression of CHS immune reactions in IFNγ-/- and TNFα-/- mice as well as
in mice which were systemically treated with neutralizing anti-TNFα antibody. Finally, therapeutic
blockade of RORγ using a specific RORγ inverse agonist (SR1001) also suppressed the DNFB induced
CHS reactions very significantly. Our data suggest that RORγ blockade will be a more effective in
suppression of CHS compared to the selective blockade of IFNγ, IL-17 or TNFα individually.
086
Impaired CCR7-mediated migration of MUTZ-3-derived Langerhans-like cells in response to
pro-inflammatory stimuli
S Bock, A Said and G Weindl Institute of Pharmacy (Pharmacology and Toxicology), Freie
Universität Berlin, Berlin, Germany
Epidermal dendritic cells (DC), Langerhans cells (LC), are recognized to play an essential role as
first-line defence against the invasion of pathogens. Here, we investigated LC obtained from the
human myeloid leukaemia cell line MUTZ-3 and human peripheral blood-derived monocytes,
respectively, as in vitro model systems to study LC differentiation and activation. After cytokine-
dependent differentiation Langerhans-like cells generated from MUTZ-3 progenitor cells (MUTZ-
LC) as well as monocyte-derived LC (MoLC) displayed an immature phenotype and showed com-
parable expression levels of the DC-specific markers CD1a and Langerin. However, flow cytometry
analysis revealed higher expression of maturation markers (CD83, CD86) on MUTZ-LC compared
to MoLC. Furthermore, a similar but distinct Toll-like receptor (TLR) mRNA expression pattern was
observed by quantitative RT-PCR. Immature MUTZ-LC expressed lower levels of TLR transcripts
involved in viral sensing (TLR3, 7, 8), but showed higher TLR1 and 2 expression when compared
to MoLC. Upon stimulation with standard maturation cocktails (TNF, IL-1β together with IL-6,
PGE2 or LPS, respectively) and soluble CD40 ligand, a significantly lower CCR7-mediated migra-
tion towards CCL21 was found for MUTZ-LC in transmigration chemotactic assays. Similar results
were obtained after stimulation with different TLR ligands. Our results demonstrate that MUTZ-LC
and MoLC share many phenotypic and functional properties although MUTZ-LC show lower migra-
tion rates which may be explained by a limited maturation phenotype. Further investigations will
allow deciphering the mechanisms involved in LC differentiation and activation to gain a more
detailed insight into LC function in vivo by using human in vitro model systems.
090
Tissue resident and central memory T cells share a single clonal origin but play distinct and
non-overlapping roles in long-term memory responses in skin
O Gaide,1 X Jiang,1 S Nizza,1 C Desmarais,2 R Clark1 and TS Kupper1 1 Harvard Skin Disease
Research Center, Department of Dermatology, Brigham and Women’s Hospital, Boston, MA
and 2 Adaptive Biotech, Seattle, WA
Tissue resident memory T cells (TRM) provide rapid and effective anti-viral protection, far superior
to that of circulating central memory T cells (TCM). In our latest work, this emerging paradigm shift
in understanding immune memory can now be extended to non-viral antigens. We used functional
in vivo and in vitro assays, parabiotic mice, and high throughput TCR sequencing, to show that sim-
ilar populations of long lived TRM cells mediate a rapid response to contact sensitizers (e.g., DNFB).
In normal mice, the local skin response of sensitized mice to DNCB is ultra-fast, site specific and
migration-independent. The antigen specific TRM cells implicated express the same surface markers
as virally-induced TRM. In contrast, mice in which development this TRM cell compartment is blocked
develop a slower, diffuse and migration-dependent response, which can be blocked by FTY720.
Importantly, this TCM response gave rise to a new population of TRM that subsequently provided a
site-specific ultra-fast and migration independent response upon rechallenge. Finally, using high
throughput TCRβ sequencing to delineate the clonal response to three distinct antigenic challenges
to skin: DNFB, an ovalbumin peptide (OVA) and Modified Vaccinia Ankara virus (MVA, a non
replicating poxvirus), in both normal and parabiotic mouse tissues, we find that expanded clones
of T cells carrying the identical antigen specific TRCβ are found in high quantities in local and dis-
tant skin, as well as the draining and distant lymph nodes. Taken together, our results indicate, for
the first time that we are aware, that a single primed naïve T cell gives rise simultaneously to TRM
and TCM that have complementary and non-overlapping roles in immune memory, and fundamen-
tally redefine our understanding of not only delayed type hypersensitivity and skin immune responses
in general.
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Systems analysis of pneumococcal vaccine response in psoriasis patients
G Obermoser,1 C Ryan,2 E Ruchaud,1 B Mansouri,1 M Patel,2 E Anguiano,1 D Blankenship,1
K Palucka1 and A Menter2 1 Baylor Institute for Immunology Reserache, Dallas, TX and 2 Baylor
Research Institute, Dallas, TX
“Exercising” the immune system by vaccination allows to dynamically investigate the human immune
system in an ethically acceptable manner and make immune alterations, not visible at steady state,
measurable. We here investigated patients with chronic plaque type psoriasis receiving either ustek-
inumab (n=15), which simultaneously blocks the IL-12 and IL-23 axis, or who were untreated with
systemic immunosuppressants or biologicals for a minimum of 8 weeks (n=18); untreated patients
were selected to match demographics and PASI scores of treated patients (median age 45 years,
median PASI 3.4). Patients received the 23-valent pneumococcal polysaccharide vaccine. Using
systems approaches, we collected in addition to detailed clinical data and complete blood counts
also samples for whole blood microarray, fresh whole blood 10-color polychromatic flow cytome-
try and serology. Measuring binding antibodies to 14 polysaccharides, no significant difference in
serological response between psoriasis patients without systemic treatment or receiving ustekinumab,
or a healthy adult control group (n=12) was noted. The quality of the antibody response (opsoniz-
ing antibodies titers) will be further investigated. While a spike in circulating
CD19+CD20lo+CD27+CD38hi plasmablasts was observed on day 7 following vaccine adminis-
tration in all groups, this immune response was significantly smaller in patients receiving ustek-
inumab compared to healthy adults (p<0.05). Likewise a day 7 increase in circulating ICOS+ CD4+T
lymphocytes was diminished both in ustekinumab treated and untreated patients compared to healthy
controls (p<0.05) while no such difference was apparent on day 0 before vaccination. This affected
both CXCR5+ and CXCR5- CD45RA- memory CD4+T cells. In summary, we here show that although
changes in immune cell composition in the blood may not be visible in psoriasis patients with mild
disease activity in the steady state, such alterations can become apparent when “exercising” the
immune system by vaccination.
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Induction of a long-lived protective mucosal T cell response by inactivated Chlamydia tra-
chomatis coupled to a TLR7 agonist by nanoparticles
G Stary,1 AF Radovic-Moreno,2 D Gondek,1 A Olive,1 PA Basto,2 OC Farokhzad,3 R Langer,2
M Starnbach1 and UH von Andrian1 1 Division of Immunology, Department of Microbiology
and Immunobiology, Harvard Medical School, Boston, MA, 2 Department of Chemical
Engineering, Massachusetts Institute of Technology, Cambridge, MA and 3 Laboratory of
Nanomedicine and Biomaterials, Department of Anesthesiology, Brigham & Women’s
Hospital, Harvard Medical School, Boston, MA
The obligate intracellular pathogen Chlamydia trachomatis (Ct) is the most commonly reported sex-
ually transmitted bacterial infection and the world’s leading cause of infectious blindness and female
infertility. We designed a vaccine consisting of inactivated Ct and a TLR7 agonist covalently linked
to nanoparticles that were attached to the microbial surface and, using a mouse model of Chlamy-
dia genital tract infection, tested its ability to induce protective immunity. Chlamydia loads of the
uterus were determined by qPCR and the Ct-specific CD4+ T cell response was analyzed by flow
cytometry. Genital and intranasal, but not subcutaneous, immunization with the construct resulted
in protection when mice were genitally challenged with infectious Ct up to six months after immu-
nization. Protection after immunization with our vaccine construct was observed in antibody-, B
cell-, and CD8-deficient mice, while RAG-2-/- mice were not protected against Chlamydia challenge.
Furthermore, we found a robust Chlamydia-specific CD4+ T cell response as determined by rate of
T cell proliferation and secretion of IFN-gamma and were able to transfer to naïve mice protection
against genital Chlamydia challenge by injecting purified CD4+ T cells from immunized mice. With
the new technologies described here, we were able to modify inactivated Chlamydia with nanopar-
ticles to induce a protective T cell response. We observed transmucosal protection as we could
specifically induce CD4+ memory cells within the genital mucosa by intranasal immunization. This
is essential for translating this vaccine against Chlamydia and possibly other sexually transmitted
infections to humans.
093
Diverse cutaneous dendritic cell subsets play distinct roles in the transport of soluble pro-
teins to draining nodes and subsequent cross-presentation to naïve CD8 T cells
ST Nizza and JJ Campbell Dermatology, Brigham and Women’s Hospital, Boston, MA
We have developed a system in which dendritic cells (DC) isolated from the skin-draining lymph
nodes of cutaneously immunized mice present their in vivo-acquired antigen to naïve CD8 T cells
ex vivo. Whole ovalbumin protein was used as the topical immunogen, as it requires processing
within DC to cross-prime naïve ovalbumin-specific OT-I CD8 T cells. DC populations from immu-
nized wild-type (WT) mice stimulated robust proliferation of OT-I cells. This system has allowed us
to explore the relative contribution of various DC subsets and DC-expressed molecules to the process
by which cutaneous antigen is delivered to antigen-specific naïve CD8 T cells. We used various
mouse breeding and cell sorting techniques to acquire greatly enriched populations of several dis-
tinct DC subsets. DC populations from immunized CCR7-deficient mice were unable to stimulate
OT-I proliferation, suggesting that migratory DC are required for cross-priming CD8 T cells, and
implying that lymph node resident DC by themselves are inadequate to perform this function. This
notion was supported by our finding that magnetic-bead-purified CD8α+ DC (a LN-resident sub-
set) from immunized WT mice were also incapable of cross-priming CD8 T cells by themselves.
DC from CCR7-deficient hosts and purified CD8α+ DC from WT hosts were efficient at cross-pre-
senting soluble ovalbumin added to the culture, implying that an element of Ag transport is required
in vivo that is bypassed ex vivo. Electronic sorting of migratory DC from LN-resident DC demon-
strated that migratory DC from immunized hosts were by themselves capable of cross-priming CD8
T cells. Further sorting of the migratory DC into CD11b+ versus CD103+ subsets demonstrated that
the vast majority of cross-priming function lies within the CD11b+ population of cutaneously immu-
nized mice. Thus, our in vivo/ex vivo system has allowed us to identify the specific DC subset most
likely responsible for presenting soluble skin-derived Ag to naïve CD8 T cells.
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Transcriptional and functional conservation between human Langerhans cells and mouse
thymic DCs
M Artyomov, A Munk, M Cella, T Tung, S Lam, R Schreiber and E Klechevsky Department of
Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO
The characterization of human DC subsets is essential for the design of new vaccines and for bet-
ter translation of mouse immunological data to the clinic. Previously, we showed that human epi-
dermal Langerhans cells (LCs) were highly efficient at priming effector CD8+ T cell responses. How-
ever, the ability of mouse LCs to cross-present antigens and drive potent CTL responses is controversial.
We used expression profiling to find the human LC equivalent in the mouse. Our studies suggest
that the mouse equivalent to the human LC are the two mouse thymic DC subsets. Our studies also
reveal a distinct genetic signature of over 25 genes, that could identify and predict which DC sub-
sets can cross-present. The cross-presentation signature was present in the human blood CD141+
DCs and correctly identified the ability of other distinct human and mouse DC subsets to cross
present. We confirmed these predictions with the functional ability of DCs to efficiently cross-
prime effector CD8+ T cells. Our studies may help bridge differences between mouse and human
DCs and facilitate the application of these data to the clinic.
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Longitudinal characterization of an antigen-specific T cell response
Y Ono,1,2 I Bustos Villalobos,1 AI Marusina,1 J Bergstrom,1 A Rizzo,1 K Kondo,1 Y Miyamura1 and
E Maverakis1,2 1 Dermatology, University of California, Davis, Sacramento, CA and 2
Department of Veteran Affairs, Northern California VA Heath Care System, Mather, CA
During the primary immune response antigen-specific T cells are activated and T cell proliferation
and differentiation occurs. Competition among different T cells specific for the same antigen helps
shape the T cell response. Following antigen clearance the immune response waynes and many T
cells under apoptosis. However, a memory response remains. These memory T cells are poised to
respond quickly and robustly to antigen rechallenge. In general, it is believed that the most high
affinity cells are selected to become components of the memory pool. By using T cell repertoire
analysis to follow the endogenous immune response to model antigens (e.g. hen eggwhite lysozyme
and myelin basic protein) in two different mouse strains (BALB/c and C57BL/6) we demonstrate that
the same T cells are generated repeatedly throughout the life of an animal and that a strikingly sim-
ilar repertoire is regenerated following myeloablation and syngeneic bone marrow transplantation.
Finally, we demonstrate that, in healthy animals, a profound repertoire shift can be observed in the
secondary immune response following antigen rechallenge. This repertoire shift depends on the con-
ditions used to prime the animals. In contrast to current dogma, we observed that high affinity anti-
gen-specific CD4+ T cells are often entirely lost during the secondary immune response, even though
they are well-represented in the primary immune response.
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Next generation T cell receptor sequencing for the identification and monitoring of patho-
genic T cells in alopecia areata
A de Jong,1 A Jabbari,1 Z Dai,1 L Xing,2 M Kurban,1 B Thompson,1 M Furniss,1 J Mackay-Wiggan,1
AM Christiano1 and R Clynes2,1 1 Dermatology, Columbia University, New York, NY and 2
Pathology, Columbia University, New York, NY
Alopecia Areata (AA) is one of the most common autoimmune diseases, characterized by non-scar-
ring hair loss. T cells are considered the critical pathogenic cells, since they abundantly infiltrate
the hair follicles in AA, and are both necessary and sufficient to transfer disease in the C3H/HeJ
mouse model of AA. Next generation T cell receptor (TCR) sequencing provides a platform to iden-
tify and track the frequency of pathogenic TCR clonotypes, representing a functional biomarker of
disease activity. Using this technique for TCR β chain sequencing, we have identified strikingly
expanded T cell clones in lesional skin from five AA patients, which represented up to 9.5% of the
total TCR sequences, supporting an antigen-driven process in AA, and providing evidence of dom-
inant pathogenic T cell clones. Comparative data from the C3H/HeJ mouse model of AA also strongly
supports this notion, as identical TCR sequences were dramatically expanded in new AA lesions of
recipient mice grafted with lesional skin from the same donor. In human AA patients, we found that
some T cell clones that were expanded in affected skin, also circulate at significant frequencies
(>0.1% of total blood sequences) in the peripheral blood of the patient. By correlating the disease
severity with the frequencies of circulating pathogenic clones, we are now testing the hypothesis
that circulating pathogenic TCR frequency distinguishes patchy Alopecia (AAP) and generalized
Alopecia (AU), and/or correlates with baseline disease severity or disease trajectory. In a longitudi-
nal study, we will determine if increased circulating pathogenic TCR frequency precedes or occur
concomitantly with disease progression. The unique accessibility of clonally expanded pathogenic
T cells within the hair follicle end organ represents an ideal clinical setting to examine the broad
applicability of next generation sequencing to identify and track pathogenic TCR clonotypes in
human autoimmunity.
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